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 Abstract 
Background and aims: The physical symptoms of chronic health conditions are well 
documented and understood, the long-term sequelae of chronic conditions are now 
also more established with a focus on improving quality of life (QoL). Established 
psychological therapies such as Cognitive Behaviour Therapy (CBT) have aimed to 
try to help individuals that are suffering with chronic conditions. A relatively new 
approach, Acceptance and Commitment Therapy (ACT), claims to be transdiagnostic 
and therefore may be a suitable approach with this population. This thesis aims to 
explore the efficacy of ACT in improving QoL in chronic health conditions. 
Methodology: A systematic literature search and analysis was undertaken utilising a 
meta-analysis approach. 
Results: A comprehensive electronic and manual search yielded a total of 1081 
potential articles. Following the implementation of the inclusion and exclusion criteria 
a total of 12 studies, including 788 participants, were included in the analysis. Data 
were extracted and studies were assessed for methodological quality. ACT led to 
greater improvements in QoL compared to control conditions and the effect size (ES) 
was small to moderate (Hedges g = .33). However, ACT was not significantly better 
than active control groups when separately analysed (g = .27, p = 0.23). 
Conclusions: The findings suggest that ACT does have a positive and significant 
effect on QoL for individuals with chronic health conditions compared to controls. 
Furthermore, these improvements in QoL are not diminished after follow-up. The 
results, theoretical/clinical implications, strengths and limitations and future directions 
of this thesis are explored in the Discussion. 
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 Chapter One: Introduction 
1.1. Overview 
The chapter provides an outline of chronic health conditions and highlights the 
importance of quality of life (QoL) within this specific population. The aetiology, 
epidemiology and treatment, both medical and psychological, of chronic pain is 
explored as an example of a chronic condition. Acceptance and Commitment Therapy 
(ACT) is described and appraised and consideration is given to how it could provide 
an alternative or supplementary form of psychological treatment for chronic health 
conditions. Finally a rationale is presented for why investigating the efficacy of ACT 
on QoL within a chronic health population is relevant. 
1.2. Chronic Health Conditions 
In 2012 the World Health Organisation (WHO) proposed that chronic health 
conditions are the leading cause of death and disability globally (WHO, 2012). 
Cancer, diabetes and cardiovascular disease accounted for 63% of all deaths 
worldwide in 2010. The Department of Health estimated that 15 million people in the 
UK have a chronic health condition. This accounts for £7 of every £10 spent on health 
and social care (Department of Health, 2012). These conditions do not currently have 
a cure and primary symptoms are predominately managed with pharmacological 
interventions. The conditions are enduring, have a poor prognosis and have a pattern 
of reoccurrence and deterioration. A wide array of conditions can be classified as 
chronic health conditions. Examples of conditions include; cancer, diabetes, 
cardiovascular disease, epilepsy, chronic pain, tinnitus, brain injury, HIV/AIDS, 
irritable bowel syndrome amongst others. Healthcare, given the nature of these 
conditions, is not targeted towards a cure but instead at improving QoL and managing 
complex symptoms (Nolte & McKee, 2008). 
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1.2.1. Definition of a chronic health condition. 
Since 1947 there has been a shared definition of health. The World Health 
Organisation (WHO) defines health as not merely the absence of disease and infirmity 
but as ―complete physical, social and mental well-being‖ (WHO, 1947, p. 1). This 
definition is particularly salient for people who suffer from chronic conditions as all 
three of these domains are affected by the illness. A clear and universal definition of 
chronic conditions however has not been established. The overwhelming criteria in 
defining chronic conditions seemed to only involve duration as a means of 
classification based on a review of literature (O'Halloran, Miller, & Britt, 2004). 
O'Halloran et al. (2004) highlighted the importance of other factors when considering 
a definition of a chronic health condition. Their definition includes: the extent to 
which symptoms recur or worsen over time; an emphasis on maintenance rather than 
curing the illness; and how sequelae impacts on a person‘s QoL. O'Halloran et al. 
(2004) concluded that chronic conditions are multi-faceted and should not be defined 
solely on their duration. Furthermore, a set of criteria were developed which 
encapsulated the multifaceted nature of chronic conditions. The criteria include; a 
duration of at least six months, a pattern of reoccurrence or deterioration, poor 
prognosis, and sequelae that impacts on QoL (O'Halloran et al., 2004). 
1.2.2. Importance of quality of life. 
The physical effect of chronic health conditions such as chronic pain, heart 
disease and cancer is well documented and well understood. Knowledge of the long-
term sequelae of chronic conditions is now also more established (Hudson & Chilcot, 
2015). The co-occurrence of chronic health conditions and psychological distress is 
associated with increased mortality, morbidity, increased healthcare costs and poorer 
QoL (Hudson & Chilcot, 2015). Cancer survivors following invasive treatments are 
often left with neurocognitive impairments that result in distress such as anxiety, 
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depression and social withdrawal (Barakat et al., 2015). Lichtman et al. (2008) report 
that depression is three times more likely following an acute myocardial infarction 
than compared to the general public. Evidence suggests that people suffering from 
chronic pain are more likely to report psychological distress due to pain, lack of sleep, 
diminished social interactions, lack of work and reduced daily activities (McCarberg, 
Nicholson, Todd, Palmer, & Penles, 2008; Smith et al., 2001). In 2012, it was 
estimated that there were 4 million people in England with a co-morbid chronic health 
and mental health condition and that many of them experienced poorer general health 
outcomes and QoL as a result (Naylor et al., 2012). As such there has been a greater 
focus on addressing psychosocial distress with the aim of improving functioning, 
well-being and QoL in chronic health conditions (Livneh, 2014; Naylor et al., 2012; 
The Department of Health, 2012, 2015).  
QoL is often an overused and all-inclusive term that has come to mean 
different things for different people. There is not a universally shared or agreed 
definition of QoL which has resulted in a number of different definitions (Barofsky, 
2011; Speight, Reaney, & Barnard, 2009). Cella and Tulsky (1990, p. 29) describe 
QoL as a cognitive appraisal based on satisfaction with a person‘s current level of 
functioning compared to their ideal. The WHO defines QoL as a person‘s perception 
of their position in life (WHO, 1997, p.1). Bowling (2005, p. 125) describes QoL as a 
sum of physical, social, emotional and objective dimensions. There is some 
commonality in these different interpretations that QoL is a multi-dimensional 
construct which is dynamic, subjective and measures physical, psychological and 
social well-being (Barofsky, 2011; Cella, 1994; Herrman et al., 1998; Speight et al., 
2009; Spilker, 1990). 
The primary aim of medical interventions within this population includes 
reducing the speed of deterioration and the management of symptoms (Naylor et al., 
2012). There is also a greater focus on alleviating emotional distress through the use 
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of psychological interventions (NICE, 2009, 2012). Given the complex nature of 
chronic health conditions there has been a greater focus in improving QoL as part of 
treatment interventions (Nolte & McKee, 2008; The Deparment of Health 2012, 
2015). By definition a condition is considered chronic based on whether it affects 
QoL (O'Halloran et al., 2004). Evidence shows that chronic health conditions affect 
physical symptoms but also on other aspects of a person‘s functioning/well-being. 
This has implications for the way outcomes are measured in chronic disease research, 
with a greater focus on QoL (Arnold et al., 2004). QoL has become an important 
outcome measure in research, and clinically, in trying to evaluate the effectiveness of 
interventions within chronic health populations (Department of Health, 2012, 2015). 
As such there has been a greater focus on psychological based interventions in trying 
to address QoL. NICE (2009, 2012) recommend psychological therapies for chronic 
health conditions such as cancer, heart disease, diabetes, musculoskeletal disorders, 
respiratory illness, and neurological disorders. NHS England have set out a number of 
outcomes and highlighted the importance of enhancing QoL for patients with long-
term conditions (http://www.england.nhs.uk/resources/resources-for-ccgs/out-frwrk/). 
Given the importance of QoL within this population there is a need to identify 
evidence based psychological interventions that can improve QoL. 
1.3. Chronic Pain 
Given the complexity and diversity of the chronic health population an 
appraisal of the relevant literature for each specific condition focusing on biology, 
epidemiology, impact, treatment and psychological understanding is beyond the scope 
of this thesis. This introduction will therefore focus on chronic pain as an example of 
a chronic health condition and explore the relevant literature. It was also expected that 
this thesis would include many articles that explore chronic pain as the treatment for 
this condition has been heavily researched in relation to ACT 
5 
(https://contextualscience.org/state_of_the_act_evidence). Furthermore, by focusing 
on one condition within the introduction it allows the chapter to flow seamlessly 
between subsections compared to abruptly changing between chronic health 
conditions resulting in re-orientation for the reader. 
1.3.1. Aetiology. 
Melzack and Wall (1965) describe pain as ―an aversive, personal, subjective 
experience, influenced by cultural learning, the meaning of the situation, attention and 
other psychological variables, which disrupts ongoing behaviour and motivates the 
individual to stop the pain‖. The International Association of the Study of Pain (IASP) 
describe pain as an ―unpleasant sensory and emotional experience‖ that is linked to 
either actual or potential tissue damage (Merskey & Bogduk, 1994, p. 210). Both 
definitions highlight the importance of an unpleasant sensation but also incorporate 
the notion of disrupting current behaviour with a compulsion to want to stop the pain. 
There is also a strong emphasis on the psychological factors of pain as an important 
factor in the understanding of pain and its subjective experience. 
The biological process involved in the sensation of acute pain begins with 
external stimulation or tissue damage and is described as ‗nociceptive pain’ (Flor & 
Turk, 2015). Receptors known as ‗nociceptors‘ when activated result in the sensation 
of nociceptive pain. Damage to nociceptors can occur through three different 
modalities; thermal stimulation (i.e., noxious heat or cold at different temperatures), 
chemical stimulation (i.e., contact with bio hazardous substances), or mechanical 
stimulation (i.e., excessive pressure or mechanical deformation including breaks in the 
skin). The body‘s physiological response begins with the transmission of signals 
through the spinal cord which in turn activate inflammation at the site of the injury. 
Fast acting messages sent immediately from the spinal cord activate muscles to trigger 
spams with the intention to avoid additional injury. The cortex is bypassed in this 
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feedback loop which ensures that the body can respond to the injury quickly. As the 
injury begins to heal there is a reduction in pain signals and sensations of pain. The 
pain is generally localised at the injury site and does not result in multiple sensations 
of pain. However, the experience of pain can be more widespread if it is linked to 
damage to internal organs.  
There is a second category of pain known as ‗neuropathic pain‘ which is 
experienced following damage to the somatosensory system (Geber et al., 2009). The 
initial physiological response from the body includes the one described above. 
However, in this circumstance there is damage to nerves which results in a different 
sensation of pain. Damage or disease affecting the somatosensory nervous system can 
lead to neuropathic pain which can be seen in spinal cord injuries, herpes zoster virus, 
alcohol abusers, diabetics, post-surgery patients such as cancer survivors (Attal, 
Lanteri-Minet, Laurent, Fermanian, & Bouhassira, 2011; Bouhassira, Lantéri-Minet, 
Attal, Laurent, & Touboul, 2008). The experience of neuropathic pain has been 
commonly described to include tingling, shooting, burning and electrical type 
sensations. Patients may also experience pain from stimuli that would not normally 
cause pain known as ‗allodynia’. Neuropathic pain is described as more severe than 
nociceptive pain and is more difficult to treat (Schmidt et al., 2009).   
Neuropathic and nociceptive pain can occur together in conditions such as 
back pain and cancer pain which can go on to become chronic. In patients with 
chronic pain, stimulation of nerves and spasms continue as if the body is still reacting 
to an injury. Traditionally chronic pain has been defined solely on the duration. That 
is, the experience of continued pain long after the natural rate of recovery from an 
injury which can range between 3 and 6 months. The continual experience of pain can 
lead to avoidance of activities (Flor & Turk, 2015) and over time this can lead to 
disuse or ‗deconditioning syndrome’ resulting in loss of muscle strength, mobility and 
cardiovascular fitness (Bortz II, 1984). 
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1.3.2. Epidemiology. 
The prevalence of chronic pain in the community is varied, between 15% and 
48%, based on surveys of the community (Bekkering et al., 2011; Bouhassira et al., 
2008; Breivik, Collett, Ventafridda, Cohen, & Gallacher, 2006; Elliott, Smith, Penny, 
Smith, & Chambers, 1999; Reid et al., 2011; Torrance, Smith, Bennett, & Lee, 2006). 
Chronic pain is more prevalent in women and the elderly affecting approximately 45-
80% of older adults in residential settings (Elliott et al., 1999; Maxwell et al., 2008; 
van Hecke, Torrance, & Smith, 2013). Being retired, out of work or in receipt of a low 
wage have also been linked with chronic pain (Flor & Turk, 2015; Smith et al., 2001; 
van Hecke et al., 2013). There is also evidence that chronic pain is an enduring 
condition with 78%  of sufferers continuing to experience pain after a four year follow 
up (Smith et al., 2001). Back pain is the second main reason for seeking medical 
advice accounting for almost 7 million GP visits annually. Furthermore, 
approximately 8.3 million working days were lost as a result of musculoskeletal 
disorders in the UK between 2013-2014 (Spence, 2014). It has been estimated that 
healthcare costs for back pain equate to a total of £1.6 billion a year (Maniadakis & 
Gray, 2000). 
Musculoskeletal conditions such as arthritis, herniated/deteriorating discs and 
back pain have been reported to make up the majority of chronic pain in the 
community (Breivik et al., 2006). The prevalence of nociceptive pain in the 
community is greater than neuropathic pain and ranges between 7-8% (Bouhassira et 
al., 2008) however, neuropathic pain accounts for greater use of healthcare services 
(Breivik et al., 2006; NICE., 2013). Approximately 33% of patients do not have a 
formal diagnosis or an obvious injury which has caused them to experience pain (The 
British Pain Society, 2013). Traditionally, the absence of a medical explanation of 
pain would lead to the diagnosis of a psychological problem and termed 
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‗psychosomatic‘; it is now recognised that pain can occur without a clear injury 
(Hadjistavropoulos & Craig, 2004). 
The relative subjective experience of pain can differ based on a number of 
variables, which can be unique to individuals such as, cause, locality of pain and 
physiological sensations. Despite the unique characteristics of individuals the 
important factor is how the condition influences everyday life such as performing 
usual activities which affects QoL. Primary symptoms in chronic pain include the 
subjective experience of pain however there can be a range of secondary symptoms 
that arise which are linked to pain. A large community based survey found that; 47% 
of suffers stated it limited their social life, 54% struggled with household chores, 65% 
had trouble sleeping, 48% had to change, or were unable to, work, 73% struggled with 
exercise, 27% struggled to maintain relationships with family or friends and 21% had 
received a diagnosis of depression (Breivik et al., 2006). These findings describe the 
immense burden of chronic pain which includes not only physical discomfort but also 
an illness which highly impacts on psychosocial well-being and QoL. 
Research investigating the link between mental health difficulties and chronic 
pain has been well established in both community and clinical samples (Bair, 
Robinson, Katon, & Kroenke, 2003; Goesling, Clauw, & Hassett, 2013; Gormsen, 
Rosenberg, Bach, & Jensen, 2010; Kroenke et al., 2013; Lerman, Rudich, Brill, 
Shalev, & Shahar, 2015). The prevalence of comorbid chronic pain and psychological 
distress has been estimated as 35% for anxiety and 40-50% for depressive symptoms 
(McWilliams, Cox, & Enns, 2003; Tunks, Crook, & Weir, 2008). Researchers have 
attempted to try to understand this link and Rudy, Kerns, and Turk (1988) suggested 
that pain and depression are mutually maintaining and do not develop from a common 
cause. They argue that depression and chronic pain results from a ―perceived 
reduction in instrumental activities along with a decline in perception of control and 
personal mastery‖ (Rudy et al., 1988, p. 129). Banks and Kerns (1996) have suggested 
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a possible role for genetics and highlight a diathesis-stress framework. They argue 
that certain genes can lead to the expression of both mental health and chronic pain 
difficulties based on an interaction between genetics and environmental influences. 
The co-morbidity of mental health difficulties and chronic health conditions lead to 
worse outcomes. Naylor et al. (2012) found that people with co-morbid mental health 
difficulties had reduced ability to manage physical health symptoms and poorer 
clinical outcomes regarding QoL. Bair et al. (2003) found that patients experienced 
greater, pain complaints, intense pain, amplification of symptoms and durations of 
pain as a result of co-morbid depression. Future episodes of pain which included 
lower back pain, chest pain, headache and musculoskeletal complaints were also 
predicted by the presence of depression. The evidence suggests that overall patients 
that have co-morbid mental health difficulties experience worse outcomes. 
Along with the link of mental health difficulties there is also growing evidence 
of a link between chronic pain and cognitive functioning. The evidence base for this is 
still growing and a few domains have been highlighted such as attention, memory and 
executive functioning. 
The experience of pain may involuntarily capture attention and interrupt pain-
unrelated cognitive activity. Eccleston and Crombez (1999) have highlighted that 
chronic pain is attention demanding and that when patients are engaged in attention-
demanding exercises there is a competition for limited cognitive resources. Legrain et 
al. (2009) investigated the effect within a laboratory setting. The effect of pain on 
attention was investigating by participants undertaking a visual attention task whilst 
simultaneously experiencing pain via a nociceptive laser stimulus. The study found 
that pain placed a demand on the attentional system and that simultaneous 
presentation of both stimuli led to the reduction of attention allocation to on-going 
cognitive processes. The sample in this study was small and only included healthy 
controls. Furthermore, the experience of pain was an acute administration and not the 
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result of prolonged exposure as is true in chronic pain. Dick, Eccleston, and Crombez 
(2002) found in a sample of 60 patients suffering with rheumatoid arthritis and 
musculoskeletal pain that scores on the Test of Everyday Attention (TEA) were 
significantly lower than aged-matched controls. Interestingly the results from the TEA 
were not correlated to the assessment of pain based on visual analogue scales. It is 
therefore not possible to conclude that the experience of chronic pain and 
performance on the TEA are related.  
There is evidence to suggest that patients suffering with chronic pain may also 
experience memory deficits. Weiner, Rudy, Morrow, Slaboda, and Lieber (2006) 
conducted a large study of older adults suffering with chronic pain. Participants 
completed a battery of neuropsychological tests which found that chronic pain was 
linked to deficits in immediate and delayed memory. Despite this finding the sample 
was an older adult population and therefore it makes it more difficult to generalise the 
results to a younger population. Interestingly there is evidence to suggest that the 
relationship between chronic pain and memory could be mediated by anxiety and 
depression. Munoz and Esteve (2005) found that patients with chronic pain that had 
complained of impairments with memory and concentration could be explained by 
symptoms of anxiety and depression. A total of 149 patients suffering with pain 
completed a battery of scales assessing memory complaints, pain catastrophising, 
depression and anxiety. The authors found that emotional distress plays an important 
role with memory in their sample and they highlighted the important factors of 
rumination and catastrophising as key factors. 
Executive functioning can be described as a supervisory attentional system 
and plays an important role in linking other cognitive resources. Executive 
functioning is an umbrella term that includes various higher order cognitive processes 
such as problem solving, planning, multi-tasking, working memory, inhibition 
control, flexibility and reasoning.  
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There is evidence to suggest that this important higher order cognitive ability 
could be impaired in people that suffer with chronic pain. Karp et al. (2006) 
investigated the relationship between chronic pain and mental flexibility in an older 
adult population utilising a cognitive battery assessment. The authors found that pain 
was not associated with impairments in short-term memory or information processing 
speed but was related to mental flexibility based on a number-letter switching task. 
Statistical analysis was controlled to account for comorbidity, sleep impairments and 
years of education. Weiner et al. (2006) described earlier with regards to memory also 
investigated executive function. A total of 323 older adults, 160 with chronic pain and 
163 matched controls completed a battery of tests. The authors reported that 
participants suffering with chronic pain were impaired on measures of mental 
flexibility and psychomotor speed compared to controls. Despite the findings from 
both of the studies it should be noted that they both utilised an older adult sample and 
that the findings can only be generalised to the older adult population. Furthermore, 
executive functioning is a complex process and should be measured with a number of 
different assessments that tap into various aspects of this multifaceted ability. The 
results from both studies would be more reliable if they had included a wider range of 
tests that covered more aspects of executive functioning.   
The link between cognitive impairments and chronic pain has been highlighted 
in the research above, however within the wider field of research the understanding of 
this link is unclear. Research has suggested that the co-morbidity of anxiety and 
depression experienced by patients with chronic pain could be modulating this 
relationship. Furthermore it would seem that the difficulties identified may centre on 
problems with bottom-up processing. Limited attentional resources could be put under 
strain following the experience of chronic pain. This may have a cascading effect on 
memory and executive functioning as the attentional system at the lowest level is 
impaired. The interaction between chronic pain and cognitive impairment is further 
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clouded with the use of long-term medication. There is evidence to suggest that long-
term opiate use may add further cognitive impairment in relation to working memory, 
information processing and cognitive flexibility (Schiltenwolf et al., 2014). There is a 
need for further investigation to clarify the cognitive profile within the chronic pain 
population (Landro et al., 2013). 
1.3.3. Theories of pain. 
The following section will outline key models of chronic pain. It is beyond 
this thesis to provide a comprehensive review of all documented models of chronic 
pain and therefore the focus will be on prominent approaches which will be discussed. 
1.3.3.1. Specificity theory. 
The specificity theory of pain was first proposed by Rene Descartes in the 16
th
 
century (Melzack & Wall, 1965). He proposed that the physical sensation of pain is 
directly related to the level of tissue damage that occurs. The theory holds true that 
minor injuries such as pricking your finger results in lower sensations of pain 
compared to a more severe injury such as severing your finger. The theory postulated 
that injury results in the activation of specific pain receptors and fibres. These in turn 
transmit pain signals through the spine towards the brain. It was therefore theorised 
that the psychological experience of pain was directly related to the extent of external 
injury. Although the specificity theory is able to explain acute sensations of pain it 
was not able to explain when patients would experience prolonged chronic pain long 
after the healing process. Furthermore, the theory was unable to explain patients that 
would experience increased levels of pain despite no, or limited, external stimulation. 
1.3.3.2. Biopsychosocial model. 
The most current understanding of how acute pain can become chronic is 
based on a biopsychosocial model (Gatchel, Peng, Peters, Fuchs, & Turk, 2007; 
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Lumley et al., 2011).  Engel (1977) was the first to introduce the biopsychosocial 
perspective on illness and highlights how the origin of illness is complex and 
multifactorial. The model states that the experience of pain is determined by the 
interaction of biological, psychological and social factors. The psychological factors 
can be broken down into three parts, cognitive, affective and behavioural processes. 
The social factors include the social/cultural context that influences a person‘s 
perception and response to physical signs and symptoms. This model proposes a 
multidimensional understanding of pain compared to early theories. A number of 
different theories and models utilise a biopsychosocial model and are described 
below. 
1.3.3.2.1. The gate control theory.   
The Gate Control Theory (Melzack & Wall, 1965), when first introduced was 
heavily criticised for abandoning the notion of a hard-wired system that results in 
chronic pain. The authors suggested a revolutionary approach which incorporated 
both biological and psychological elements in the form of a dynamic system in trying 
to understand the sensations of pain. The theory has been the most influential model 
to understanding pain, it has highlighted the important role of psychological factors in 
pain and it has been argued that there is still not a more comprehensive overall theory 
of pain modulation (Hadjistavropoulos & Craig, 2004; Sufka & Price, 2002). The 
theory posits that signals from the injury site are sent to the brain via nerve fibres to 
the dorsal horn in the spinal cord. Here a gating mechanism is opened or closed 
depending on the type of nerve that is excited. Emotional reactions to pain are thought 
to influence the gating mechanism. It was proposed that high levels of expressed 
emotions would lead to the gate being opened wider leading to greater signals of, and 
therefore experience of, pain. The theory was able to explain how the sensation of 
pain is not directly linked to the extent of tissue damage or external stimulation. The 
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link between emotional and biological processes has been demonstrated and the 
theory has received support based on findings from neuro-imaging research (Gatchel 
et al., 2007; Main, 2013; Melzack, 2001). Despite this the theory does oversimplify 
and make architectural errors regarding the neuronal structure within the spinal cord 
(Nathan & Rudge, 1974). Furthermore there is evidence that suggests a critical role of 
the brain stem in sending modulating messages. It was previously thought that only 
emotional reactions emanating from the cortex modulated the gating mechanism. It 
can therefore be concluded that modulation of the experience of pain does occur 
outside of the neo cortex within the brain stem (Treede, 2006).  
1.3.3.2.2. Behavioural model. 
The key principle in the behavioural model is operant conditioning and how it 
is instrumental in maintaining ‗pain behaviours‘ (Fordyce et al., 1973). Pain 
behaviours can be described as any behaviour that is displayed in response to pain and 
can include verbal agitation, altered gait, avoidance of activities or requesting/taking 
medication. It was hypothesised that sympathetic responses from others to pain 
behaviours (e.g., providing comfort or reassurance) led to them being reinforced 
through operant conditioning. It was thought that patients would then demonstrate 
behaviours as signals to others that they were in pain. This was regardless of whether 
pain was experienced. A repeated cycle of this type of behaviour was hypothesised to 
exacerbate recovery. Research into the behavioural approach has found that when 
pain behaviours are not reinforced the frequency of these behaviours does decrease as 
a form of extinction. Furthermore positive verbal reinforcement for coping with 
activities (e.g., socialising, chores, walking, riding a bike) has been shown to increase 
their frequency and have been defined as ‗well behaviours‘ (Cairns & Pasino, 1977; 
Fordyce et al., 1973).  
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Turk and Rudy (1991) criticise the behavioural approach and highlights that 
learning new behaviours is the easy part but maintaining these is difficult especially if 
these new behaviours are not reinforced. Cairns and Pasino (1977) found that when 
verbal reinforcement was removed it would lead to an extinction of ―well-behaviours‖ 
and a return to ―pain behaviours‖ potentially leading to an exacerbation of symptoms. 
Therefore under this model the learning of new behaviours is relatively 
straightforward however it requires substantial effort from the patient and significant 
others for the benefits to be achieved and maintained.  
1.3.3.2.3. Fear-avoidance model. 
The Fear-Avoidance Model (Lethem, Slade, Troup, & Bentley, 1983) 
proposes that an individual may avoid tasks such as movement, leisure activities and 
social interactions based on fear that it will lead to increased levels of pain. The 
notion of fear is underpinned by the term ‗catastrophic thinking‘ whereby individuals 
make predictions about the nature of, consequences of and ability to, cope with pain. 
Catastrophic thoughts are hypothesised to lead to a fear of experiencing pain, hyper 
vigilance to pain sensations and avoidance behaviours in anticipation of experiencing 
pain. This can result in a vicious cycle leading to prolonged avoidance of certain 
movements which can lead to loss of physical conditioning, known as the 
deconditioning syndrome described earlier (Bortz II, 1984). In the long-term this can 
exacerbate a person‘s functional impairment through disuse as well as emotional 
distress resulting from the inability to engage in normal social roles. The model has 
received strong support regarding the connections between  elements of the model 
(Vlaeyen & Linton, 2000). It has been found that pain-related fear is associated with 
impaired physical performance and increased self-reported disability (Heuts et al., 
2004; Nederhand, Ijzerman, Hermens, Turk, & Zilvold, 2004; Vlaeyen, Kole-
Snijders, Boeren, & Van Eek, 1995). Interventions aimed at reducing negative 
16 
attitudes and beliefs that mediate avoidance behaviour can reduce pain related 
absences from work (Buchbinder, Jolley, & Wyatt, 2001). The model includes 
previous ideas regarding how emotions can influence pain but also incorporates a 
cognitive element. The model includes cognitions made regarding pain and also the 
beliefs and expectations about what it means to experience pain.  
It should be noted that the fear-avoidance model only accounts for the 
development and maintenance of chronic pain within the sub-group of chronic lower 
back pain (Leeuw et al., 2007). Furthermore there may well be different processes 
other than just fear that lead to the progression of lower back pain and therefore this 
model takes a reductionist approach.  There is not a linear relationship between fear of 
pain and symptoms of chronic pain and therefore there could be other factors which 
are influential as lower back pain can be an erratic and recurrent problem. The 
population is diverse and other factors such as pain intensity, level of disability, 
occupational consequences and use of health care can vary considerably (Leeuw et al., 
2007). 
1.3.3.2.4. Third wave behavioural models. 
Traditional western ideology regarding human suffering is based on a ―healthy 
normality‖. This is the idea that if one is not healthy, happy, content, satisfied then 
one is abnormal and that something is wrong which needs to be fixed (S. C. Hayes, 
Strosahl, & Wilson, 1999). It is understandable that modern societies have come to 
this conclusion given the success of modern medicine whereby physical illnesses, to a 
large extent, are resolved through interventions which alleviate suffering and health is 
simply the absence of disease. Therefore abnormality is seen as a disease, symptom or 
illness which must be eradicated in order to return to a healthy normality. Traditional 
psychological understanding and treatment of human suffering has also utilised this 
same approach and has been championed by the most evidence based psychological 
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therapy Cognitive Behaviour Therapy. People are seen as dysfunctional beings with 
faulty cognitions and experiencing the wrong emotions and therefore must be 
challenged to think differently and try their best to feel something different. 
It could be argued that the assumption of a healthy normality should be 
challenged and that not being healthy, happy, content, satisfied is natural and a normal 
part of human existence and one that does not make someone abnormal. This has led 
to a lot of interest in ‗Third-wave‘ behavioural approaches, in particular mindfulness-
based models and Acceptance and Commitment Therapy known as ‗ACT‘ (S. C. 
Hayes et al., 1999; Kabat-Zinn, 1982, 1990). These approaches share a similar 
philosophy that incorporates the idea that human existence includes a wide array of 
experiences which includes ‗pain‘. The notion that pain is ubiquitous to life implies 
that you can‘t eradicate it. Third-wave behavioural approaches do however state that 
that we can choose how we live with this pain. A core component of both approaches 
is ‗mindfulness’. Kabat-Zinn (2003, p. 145) describes mindfulness as ―the awareness 
that emerges through paying attention on purpose, in the present moment, and non-
judgementally to the unfolding of experience moment by moment‖. This ideology is 
incorporated into mindfulness-based stress reduction programmes which have 
evidenced reductions in psychological distress and improvements in QoL for people 
suffering with chronic pain (Grossman, Tiefenthaler-Gilmer, Raysz, & Kesper, 2007; 
Kabat-Zinn, Lipworth, & Burney, 1985; Pradhan et al., 2007; Sephton et al., 2007). In 
section 1.4 the model of ACT, theoretical underpinning of ACT and evidence for this 
approach will be explored across different chronic conditions. 
1.3.4. Treatment. 
Patients suffering with chronic pain present at primary care services which 
predominately utilise a biomedical approach in an attempt to relieve pain. Patients that 
do not respond to this approach are then referred on to specialist pain management 
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services that incorporate interdisciplinary teams that utilise a biopsychosocial model. 
Services aim to reduce pain. In circumstances where this cannot be achieved the focus 
of treatment is on reducing disability, mental health difficulties associated with pain 
and improving QoL (Department of Health, 2012, 2015). Services can provide 
surgical interventions, medication, physiotherapy, and spinal stimulation-induced 
analgesia. The British Pain Society (2013) highlight the importance of education 
provided by services which cover topics such as scheduling activities, use of aids, 
self-management, and the role of emotions. Increasingly pain management services 
are offering psychological interventions provided by clinical psychologists utilising 
cognitive behavioural, mindfulness and acceptance-based approaches (The British 
Pain Society, 2013). 
1.3.4.1. Behavioural therapy. 
The popularity of the behavioural approach led to the development of 
behavioural treatment programmes utilising classical reinforcement techniques. As the 
model states the aim of the therapy is to reduce pain behaviours with the use of 
operant conditioning whilst attempting to increase well behaviours. Morley, 
Eccleston, and Williams (1999) reported a decrease in frequency and intensity of pain 
behaviours, reduced anxiety and increased social functioning in a review of 
behavioural therapy compared to a waiting list control (WLC) in a meta-analysis (M-
A). Despite its popularity and promising findings the behavioural model has come 
under considerable criticism (Sharp, 2001; Turk, 1996). Relapse following treatment 
programmes is high suggesting that the target of treatment does not address the 
underlying factors that maintain pain. The concept of pain behaviours is ill-defined 
and the suggestion that they are dysfunctional is not substantiated. The aim to 
extinguish behaviours is not often shared by patients and can lead to the 
underreporting of symptoms resulting in medical mismanagement such as reductions 
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in medication and failure to investigate new symptoms by clinicians (Turk, 1996; 
Turk & Rudy, 1991). 
1.3.4.2. Cognitive-behavioural therapy. 
Cognitive Behavioural Therapy (CBT) has a substantial evidence base and has 
therefore been the primary therapy for chronic pain management for a number of 
years. The primary target for treatment in CBT is on ‗cognitive restructuring‘, 
changing thoughts/beliefs about pain, and changing behaviour. Treatment also 
includes a number of behavioural techniques which can include pacing, activity 
scheduling, and relaxation strategies (Morley, Williams, & Hussain, 2008). The Fear-
Avoidance Model has been an integral part of the CBT approach and components of 
the model including changes in catastrophic thinking, pain beliefs, and self-efficacy 
have been shown to result in increases in physical functioning (Jensen, Turner, & 
Romano, 2007; J. A. Turner, Holtzman, & Mancl, 2007; Vowles, McCracken, & 
Eccleston, 2007). 
There have been however mixed results regarding the efficacy of CBT. 
Glombiewski et al. (2010) conducted a M-A of the efficacy of CBT within a 
fibromyalgia population. They found a significant small effect for pain reduction in 
the short-term and small to medium effect for long-term pain reduction over an 
average of 7.4 months based on 23 eligible studies. The research noted that many of 
the included studies in the M-A were of poor quality and were uncontrolled. 
Furthermore, different psychological treatments were pooled together bringing into 
question the integrity of the CBT approach in the analysis. Bernardy, Fuber, Kollner, 
and Hauser (2010) conducted a M-A of the efficacy of CBT within a fibromyalgia 
population. They found a small effect in improving depression however CBT was 
grouped together with alternative treatments such as behavioural therapy and 
mindfulness-based stress reduction (MBSR). In seven out of the 13 studies CBT was 
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the main intervention however it is not possible to distinguish its effect from the other 
interventions in the analysis. Furthermore, there was considerable heterogeneity for 
multiple outcomes used in the research. Eccleston, Williams, and Morley (2009) 
reported a weak treatment effect for disability, pain, and psychological distress at 
follow-up when compared to active control groups in a review of studies. Researchers 
have questioned the treatment fidelity of many studies and that key parts of the CBT 
approach were missing which may have reduced the effectiveness of CBT (Eccleston 
et al., 2009; Morley, 2011). Morley et al. (2008) found in a large sample that 25% 
reported reduced levels of pain and 33% reported reduced depression and anxiety 
based on a four-week CBT-informed pain management programme. The gains 
received by the minority of this sample is important but it does highlight the need for 
further research into why CBT is effective for some and not others (Crombez, 
Eccleston, Van Damme, Vlaeyen, & Karoly, 2012; Vlaeyen & Morley, 2005).  
It has been argued that it is unclear how the various ingredients of CBT are 
linked with modifications in functional disability and levels of pain, or if these are 
similar in all patients (Keefe, Rumble, Scipio, Giordano, & Perri, 2004; Morley & 
Keefe, 2007). Furthermore, improvement in psychological outcome can occur despite 
no cognitive restructuring (Longmore & Worrell, 2007) which questions if this is 
important for change. There has been a rise in the popularity of alternative 
psychological treatments that pay less, or no, emphasis on cognitive restructuring and 
instead focus on the relationships between cognitions, emotions and physical 
sensations and how together they can influence behaviour. This further confuses the 
picture regarding what the important mechanisms for change are. 
1.3.4.3. Mindfulness-based stress reduction 
Mindfulness-based stress reduction (MBSR) is a manualised group-based 
intervention which integrates Buddhist mindfulness meditation with Western clinical 
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and psychological practices (Kabat-Zinn, 2003; Kabat-Zinn et al., 1985). The 
approach was originally developed for patients with chronic pain during the 1970s 
(Kabat-Zinn, 1990). MBSR encourages participants to bring their focus towards the 
present moment and change their attitude to one of acceptance and openness without 
self-judgement. The intervention predominately comprises eight weekly group 
sessions and includes three different techniques; awareness of breathing, body scan 
(e.g., shifting attention across the entire body from head to toe) and ‗hatha yoga’ 
which includes breathing, stretches and postural exercises. 
A number of studies have been conducted regarding the efficacy of the 
approach and have found promising results. Astin et al. (2003) found that patients 
suffering with fibromyalgia reported improvements in pain, disability and depression 
post-MBSR and that these improvements were maintained at six-months follow-up. 
Grossman et al. (2007) conducted a randomised controlled trial (RCT) and found that 
MBSR, compared to progressive muscle relaxation, resulted in significant 
improvements for QoL, coping with pain, anxiety, depression and somatic complaints 
in a chronic pain sample. Morone, Greco, and Weiner (2008) found that MBSR 
resulted in significant reductions in self-reported pain and improvement in chronic 
pain acceptance within a lower back pain population. The evidence base for MBSR is 
growing and guidelines in Scotland have added MBSR as a recommended treatment 
option for the management of pain (SIGN, 2013). 
1.4. Acceptance and Commitment Therapy 
ACT proposes a transdiagnostic approach of psychological well-being (S. C. 
Hayes et al., 1999; S. C. Hayes, Strosahl, & Wilson, 2011) and has therefore been 
considered across different populations where there is psychological suffering (Öst, 
2008, 2014). ACT is a mindfulness and acceptance-based therapy that has been 
influenced by radical behaviourism and a theory of language and cognition known as 
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Relational Frame Theory which is explored in section 1.4.1. It was developed in the 
1980s and formalised into a therapy in the 1990s (S. C. Hayes et al., 1999). ACT 
proposes that human suffering is a result of a dysfunctional relationship with ‗private 
experiences‘ (e.g., thoughts, emotions and bodily sensations) and neglecting values 
(e.g., not pursuing what is truly important in life) (S. C. Hayes et al., 2011). The 
overall aim of ACT is to improve a person‘s ‗psychological flexibility‘; the ability to 
connect with the present moment fully and, based on the situation, to persist or change 
behaviour, in the service of living a valued life (Harris, 2006, 2009; S. C. Hayes et al., 
1999). There are six components to the ACT model which are described in detail 
below and illustrated visually with the ‗hexiflex‘ in Figure 1.1. 
 
Figure 1.1.The ACT Hexiflex (Harris, 2009). 
23 
‗Acceptance‘ can be described as a willingness to experience physical 
sensations and emotions without the need to suppress, avoid or control them (Harris, 
2006). The willingness to engage in these experiences highlights ‗giving up on the 
struggling with pain‘ which allows for a natural level of physical and emotional 
discomfort (Harris, 2006). The opposite inflexible approach ‗experiential avoidance‘ 
occurs when attempts are made to avoid, suppress or control private experiences (S. 
C. Hayes et al., 1999, 2011). Experiential avoidance may provide short-term relief 
from symptoms (e.g., a socially anxious person avoiding crowds will not have to feel 
anxious) but this can prevent them from engaging in activities that are valued (e.g., 
losing contact with friends) which reduces psychological flexibility (Harris, 2006, 
2009). 
‗Defusion‘ is the process of distancing from the content of thoughts which can 
therefore undermine their influence (S. C. Hayes et al., 1999). Thoughts are therefore 
interpreted in a different context and viewed as just thoughts and not facts or rules that 
must be followed. The inflexible approach ‗cognitive fusion‘ refers to the dominance 
that a particular thought can have which can then influence behaviour (S. C. Hayes et 
al., 1999). People can be described as fused when they have a strong belief in a 
cognition (e.g., ―I am fat‖) and engage in accordance with it (e.g., over eating 
unhealthy food), even if this is inconsistent with their goals (e.g., weight loss) or 
values (e.g., being healthy) leading to psychological inflexibility. 
‗Contact with the Present Moment‘ emphasises the importance of focusing on 
the here and now; connecting with external senses and internal private experiences at 
the current moment in time (Harris, 2006, 2009). The inflexible approach involves the 
‗dominance of the conceptualised self’ based on self-judgements either about the past 
or future events. Poor contact with the present moment may lead people to ‗live in 
their heads‘ fixated to the content of thoughts about the past/future which results in 
disconnection with the here and now resulting in reduced psychological flexibility.  
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‗Self-as-Context‘ focuses on taking an observer stance, almost looking at 
yourself in the third person, making you aware of where your private experiences 
come from. It can be understood as ‗pure awareness‘ a space where one is free to just 
observe thoughts, emotions and physical sensations. When others are encouraged to 
see the self-as-context they distance themselves from their conceptualised self which 
may be filled with negative appraisals about themselves. This leads to a more de-
centred self. The inflexible approach leads to ‗attachment to the conceptualised self’ 
regarding the past and future. One can become consumed by the content of negative 
ruminations about the past (e.g., ―I shouldn‘t have said that‖, ―I am a horrible 
person‖) or negative predictions about the future (e.g., ―Because I said that everyone 
will think I am a horrible person‖) which further reduces psychological flexibility 
(Harris, 2009). 
‗Values‘ represent the things that truly matter to someone in their life. They 
differ from goals in that they are never fully achieved and are more like a guide to 
living life i.e., being compassionate, being funny, and being helpful. They are a way 
of being which is in line with what is meaningful for that given person (Harris, 2009; 
S. C. Hayes et al., 1999, 2011). ACT proposes that when people have clear values 
they have a good appreciation about what is important to them in life. The inflexible 
approach results when people lack values, have unclear values, have lost contact with 
their values or have become fused with values. The lack of clear values results in 
behaviour being guided by fusion and experiential avoidance which takes people 
away from what is important in life (Harris, 2009; S. C. Hayes et al., 2011). Values 
should also be ‗held lightly‘ as fusion with values turns them into ridged rules rather 
than a guide to living life which reduces psychological flexibility.    
‗Committed Action‘ is about taking effective action towards living life in line 
with values (S. C. Hayes et al., 1999). It is the application of values that brings about 
observable changes in behaviour. Whilst in the pursuit of value directed behaviour, 
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described as ‗value congruence‘, there is a possibility that it could give rise to 
pleasant and unpleasant private experiences. Committed action involves ‗doing what 
it takes‘ to live a life based on values even if this brings up pain and discomfort. The 
inflexible approach includes ‗unworkable actions‘, these are behaviours that take you 
away from valued living, increase struggles and contradict actions required to live a 
valued life. This can include actions that are; impulsive, reactive, automatic, 
procrastinatory or motivated by experiential avoidance leading to further suffering 
and reduced psychological flexibility. 
The six components of the ACT model are intimately linked and therefore 
changes in one part of the hexiflex may lead to improvements in others (Fletcher & 
Hayes, 2005; S. C. Hayes, Luoma, Bond, Masuda, & Lillis, 2006). An increase in 
defusion would lead to an increase in self-as-context and the present moment focus. 
This may allow the person to help clarify their values and make committed actions 
towards value congruent behaviours. 
The process of change is achieved by learning mindfulness skills, using 
experiential learning (e.g., learning through experience) and employing techniques 
such as the use of metaphors and paradoxes which act as shortcuts in understanding 
(Harris, 2009). The theory that underpins ACT is explained in section 1.4.1 (S. C. 
Hayes et al., 1999, 2011). As stated previously ACTs primary goal is to improve 
psychological flexibility and to promote living a valued life. ACT is not directly 
targeted to reduce symptoms such as depression or anxiety but acknowledges that 
symptoms can reduce as a by-product of living a valued and meaningful life (Harris, 
2006, 2009). What separates ACT from traditional CBT is the acceptance of negative 
thoughts and emotions without trying to avoid, control, or suppress them. ACT, rather 
than challenging thoughts and attempting to control feelings, teaches to embrace all 
thoughts and feelings. This change in attitude towards private experiences seems 
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highly relevant for chronic conditions where there is evidence of painful private 
experiences (Naylor et al., 2012). 
To place the therapy in context it may be helpful to consider the elements of 
the hexiflex in relation to a chronic health condition such as chronic pain. From an 
ACT perspective it can be argued that patients suffering with chronic pain will 
experience physical sensations of pain, thoughts about pain and emotions related to 
pain. The model would suggest that individuals that are unwilling to experience this 
and are not accepting of it will try their best to experientially avoid it such as, taking 
lots of pain relief, avoiding activities and attempts at distracting from physical 
sensations and thoughts (i.e., ―I can‘t live with this pain‖, ―my life is over‖, ―things 
will never change‖). This may lead to additional suffering such as, side effects from 
medication (i.e., stomach ulcers, kidney damage, liver damage, cognitive 
impairments), neglecting activities that make their life meaningful (i.e., spending time 
with family, going to work, and leisure pursuits), amplifications of sensations and 
dwelling on thoughts which leads to additional suffering (i.e., sadness, anger, 
anxiety).  
Unwillingness to experience pain and having thoughts regarding pain may 
lead to an increase in suffering. In order to reduce this additional suffering there is a 
need to separate the ―self‖ from the content of the mind and increase willingness to 
experience painful sensations. This is achieved through the practice of mindfulness 
which aids connection with the present moment. Pain in all its forms should be 
accepted only when behavioural change is needed towards valued living. 
With the development of these psychological skills it may allow for the 
clarification of values i.e., being courageous, being creative, being sociable etc. 
Furthermore, this would lead to the development of committed actions in line with 
values such as, climbing a mountain, drawing a self-portrait, going to a restaurant 
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with friends. Importantly, it would be the pursuit of such endeavours together with 
private experiences as living a valued life is the only form of life that is lived. 
1.4.1. Theory of acceptance and commitment therapy. 
ACT is grounded in functional contextualism (FC) and relational frame theory 
(RFT) (Fletcher & Hayes, 2005; S. C. Hayes et al., 1999). FC draws from radical 
behaviourism which states that behaviour includes not only what others can 
experience (e.g., walking, talking) but also mental processes (i.e., thinking) and 
sensory input (i.e., physical and emotional feelings) which are termed private 
experiences (Skinner, 1957, 1975). Private experiences are not inherently harmful, 
however they can function in a way that leads to suffering (e.g., an agoraphobic who 
is unable to leave their home due to thoughts of danger). ACT teaches people to 
become aware of their behaviour and notice how it functions in the context of their 
life known as ‗workability‘. 
RFT is a theory of language and cognition and focuses on how humans derive 
relationships, develop complex relational networks and transform functions leading to 
‗relational framing‘ (Fletcher & Hayes, 2005; Harris, 2009). RFT purports that 
humans can learn without having direct experience which contradicts applied 
behavioural analysis (ABA) where antecedents, behaviour and consequences through 
direct experience result in learning (Skinner, 1975). When learning language however 
children are able to derive relationships without having direct experience (e.g., the 
sound of the word ―dog‖ relates to a picture of a dog). When the same child sees a dog 
in real life they make the sound ―dog‖ as they have derived the relationship even 
though it is not the same as the picture. If the child is bitten by a dog this may 
associate it with fear based on ABA. Fear would now be in a complex relational 
network of many relations regarding ―dog‖ (e.g., the word dog, picture of a dog, 
sound of a dog, smell of a dog, the feel of a dog). The child may then respond in fear 
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when presented with the sound of a dog which is a derived relationship and has not 
been learned through direct experience. This can now be taken a step further by 
getting the child to say ―perro‖ which may mean nothing to the child however once 
they are told ―perro‖ means dog in Spanish its function has been transformed and is 
now a part of the complex network. In RFT, FC is applied as a means for extending 
radical behaviourism to account for complex cognitions and language and this is 
known as relational framing (S. C. Hayes et al., 1999, 2011). 
The ability to use relational framing is very important as it allows you to talk, 
plan, imagine, compare, invent, solve problems and so on. Within ACT the use of FC 
and RFT, within a clinical setting, relates to how relational framing (e.g., thinking, 
cognition, human language, the mind) can also lead to human suffering based on the 
development of complex networks about the self (S. C. Hayes et al., 2011). Fletcher 
and Hayes (2005, p. 318) propose that ―psychopathology evolves in part because 
derived relations dominate over other sources of behavioural regulation due to an 
inability to detect the ongoing process of thinking as distinct from the products of 
thinking‖. The aim of ACT is to distance the self from painful private experiences by 
increasing psychological flexibility. This is achieved by changing the context in 
which they occur and therefore reducing the function of these experiences without 
having to try to change the content of them (Harris, 2009). 
1.4.2. Research evidence. 
Corrigan (2001) argued that utilising ACT within a clinical setting was 
premature due to the lack of empirical evidence. Over the past 15 years there has been 
a surge of evidence in defining/measuring the concepts involved in ACT and its use in 
clinical trials (Öst, 2008, 2014). A measure of acceptance, the Acceptance and Action 
Questionnaire (AAQ) has been developed (S. C. Hayes et al., 2006) as an internally 
consistent measure of ACTs model of mental and behavioural effectiveness. AAQ 
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was designed to measure experiential avoidance; low scores on the scale would 
indicate a willingness to experience unwanted private experiences in the pursuit of 
valued living. It has been reported that the AAQ predicts a wide-range of QoL 
outcomes. 
A M-A of 27 studies that used this measure found that it predicted depression, 
anxiety, general mental health, job satisfaction, future work absence and future job 
performance with an effect size (ES) of, r = .42 (Chawla & Ostafin, 2007; S. C. Hayes 
et al., 2006). Ruiz (2010) reported that from 20 studies a range of correlations have 
been reported between depression scores and the AAQ, r = .37 to r = .77. 
Furthermore, in 14 studies anxiety symptoms correlations for the AAQ ranged 
between, r = .16 and r = .76. Despite these findings the AAQ does have its 
shortcomings. Scale brevity, item wording and item selection procedures have 
resulted in low alpha levels (McCurry et al., 2004). As a result the AAQ-II was 
developed to address these issues and has a strong correlation, r = .97 with the AAQ 
(Bond et al., 2011). Initially the scale was defined by the word acceptance however as 
ACT has evolved and developed, the term psychological flexibility has become more 
prominent and a better overarching description for the ACT model. The AAQ-II is 
therefore a measure of psychological flexibility but can still be described by the 
construct of acceptance and experiential avoidance.  
There have been a number of RCTs conducted with ACT across a number of 
different populations with a significant concentration within chronic pain (A-Tjak et 
al., 2015; DerSimonian & Laird, 1986; Öst, 2008, 2014). The following sections will 
provide evidence from RCTs investigating ACT within different populations 
including psychiatric and somatic disorders.  
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1.4.2.1. Evidence for ACT in psychological disorders. 
Folke, Parling, and Melin (2012) found that participants on long-term sick 
leave, due to depression, when randomised to ACT improved regarding levels of 
depression, general health and QoL compared to controls. L. Hayes, Boyd, and Sewell 
(2011) reported improvements in depression and global functioning for a sample of 
adolescents. The findings seem promising however in both studies the control group 
received less therapeutic input which brings into question the validity of the 
conclusions. 
Hayes-Skelton, Roemer, and Orsillo (2013) concluded that ‗acceptance-based‘ 
treatment is a viable alternative for treating generalised anxiety disorder (GAD). 
Participants improved significantly and at the same rate as controls in an applied 
relaxation group on measures of GAD severity, anxiety, depression and QoL. The 
authors acknowledged that there could have been contamination between the two 
groups regarding the intervention. Twohig et al. (2010) reported on findings from an 
RCT investigating ACT compared to progressive relaxation training with patients 
suffering from obsessive compulsive disorder (OCD). They found greater 
improvements at post treatment and follow-up for OCD severity in the ACT group. 
Furthermore, depression reduced amongst patients reporting a mild level at pre-
treatment and greater gains were observed in QoL for the ACT group. It should be 
noted that progressive relaxation training is not an established treatment for OCD and 
its appropriateness as a control condition is questioned. 
A preliminary controlled effectiveness trial with trainee therapists found that 
participants with mixed presentations, predominantly depression, mood problems and 
anxiety, showed significantly greater improvements in an ACT condition compared to 
CBT. A total of 14 participants in each group received ten 60-minute sessions of 
either ACT or CBT. Treatment was delivered by trainees who were new to both CBT 
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and ACT and who were taught and supervised by the authors. Improvements were 
reported in general mental health, social functioning, life satisfaction and depression. 
The study did however have limitations; the sample was small and from a general 
outpatient population seeking support for undiagnosed self-reported problems. 
Supervisors taught the trainees both approaches but recognise that they could have 
been biased towards ACT. Furthermore, the CBT approach was not comprehensive 
and was missing some components such as cognitive restructuring. 
ACT has been utilised within drug addiction population, Luoma, Kohlenberg, 
Hayes, and Fletcher (2012) found that residents at a drug treatment program showed 
smaller immediate gains in shame from three two-hour sessions of ACT compared to 
treatment as usual (TAU). Participants reported greater reductions after a four-month 
follow-up. Furthermore, those in the ACT group also had fewer days of substance use 
and higher treatment attendance at follow-up. The authors concluded that utilising 
ACT and focusing on shame produces better treatment attendance and reduced 
substance abuse. The study suffered from a significant amount of missing data at 
follow-up but did still utilise an intent-to-treat analysis. Also the measure of shame 
used in the study correlates with guilt and therefore it is unclear what ACT was 
targeting. 
ACT has also shown some promising evidence within a borderline personality 
disorder (BPD) population with two RCTs reporting ACT as significantly better than 
TAU (Gratz & Gunderson, 2006; Morton, Snowdon, Gopold, & Guymer, 2012). 
Gratz and Gunderson (2006) conducted a RCT with women with BPD and self-harm 
utilising a 14 week ACT intervention. Results indicate that those that received the 
intervention showed significant positive improvements on emotional dysregulation, 
experiential avoidance, self-harm behaviours, BPD-specific symptoms and symptoms 
of depression, anxiety and stress. The intervention utilised in this RCT had elements 
of dialectical behavioural therapy and behaviour therapy and therefore it is difficult to 
32 
distinguish the sole effect of ACT. Morton et al. (2012) reported significant 
improvement from baseline in the ACT plus TAU group compared to TAU alone. The 
treatment consisted of 12 two-hour sessions. Participants showed significant 
improvements on self-reported BPD symptoms along with improvements on 
hopelessness, psychological flexibility, emotion regulation, mindfulness and fear of 
emotions. The results appear promising however the TAU condition received six 
hours of treatment compared to 24 hours in the active treatment condition. 
Furthermore, both studies had small samples and the control condition did not include 
an active treatment which is a better control than TAU. 
1.4.2.2. Evidence for ACT in somatic conditions. 
Chronic pain has by far the largest amount of research regarding ACT. 
Johnston, Foster, Shennan, Starkey, and Johnson (2010) utilised a self-help 
intervention within a chronic pain population comparing ACT to a WLC. A total of 14 
participants, 11 in the ACT group and eight in the WLC were included in the study. 
The ACT group read a self-help book for a six-week period with weekly telephone 
support. Significant improvements were noted for acceptance, QoL, satisfaction with 
life, values and pain ratings. The study however had a small sample size and the 
control group was inappropriate as a comparison because it did not involve an active 
treatment. 
Mo'tamedi, Rezaiemaram, and Tavallaie (2012) conducted a RCT with an all-
female chronic pain population comparing ACT with TAU. Eleven participants in the 
ACT group received eight weekly sessions of therapy plus TAU (medical treatment) 
compared to 15 in the TAU only group. They found that the ACT group reported 
significant improvements regarding affective distress and disability. The study 
however did not use an appropriate control group such as an alternative therapy and 
had a small sample size. 
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      Buhrman et al. (2013) conducted a RCT utilising an internet-delivered 
ACT for chronic pain. Thirty-eight participants were allocated to either receive a 
seven week internet ACT for chronic pain compared to a control group that took part 
in a moderated online discussion forum. The authors report that the ACT group 
showed significant increases regarding activity engagement and pain willingness 
based on the Chronic Pain Acceptance Questionnaire (CPAQ) which is a chronic pain 
version of the AAQ-II. Furthermore, reductions were also noted regarding pain-
related distress, anxiety and depressive symptoms. The control group used in this 
study was not appropriate given that it was not an active therapy and it was only 
moderated and not monitored for activity. The authors also acknowledge that the large 
number of outcome measures used in the study may have inflated the risk of chance 
findings.  
McCracken, Sato, and Taylor (2013) randomised 73 participants to either ACT 
for chronic pain (n=37) or TAU (n=36). The ACT condition included 4 four-hour 
group sessions over two weeks. Participants in the ACT group at post-treatment 
demonstrated lower depression and higher ratings of overall improvement. At three-
month follow the ACT group reported lower disability, less depression and 
significantly higher pain acceptance. Intent-to-treat analysis revealed only significant 
effects in favour of ACT for depression and disability. The study had adequate power 
to detect effects however the control group was not suitable as it was TAU and not an 
active treatment control.  
Hesser et al. (2012) applied a self-help internet-delivered ACT protocol with a 
tinnitus population compared to an internet-delivered CBT protocol. In this RCT 35 
participants received ACT and 32 CBT with an additional 32 in a control group 
involving a monitored internet discussion forum. They reported significant 
improvement regarding tinnitus severity and distress in both the ACT and CBT group 
compared to the control at post-treatment. Furthermore, they reported no significant 
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difference between ACT and CBT highlighting that ACT may be a viable alternative 
to traditional CBT in the management of tinnitus. This study had a much larger 
sample size compared to the studies described above. The control condition was an 
internet discussion forum and therefore nonspecific effects cannot be ruled out (i.e., 
having a forum may provide attention and emotional/social support). The CBT and 
ACT protocols differed regarding their content in that the CBT protocol utilised 
written text with the ACT protocol relying more on pictorial information and 
experiential exercises. The evidence for internet-delivered or self-help ACT protocols 
is still in its infancy and therefore there is a need for more research in this area before 
this can be deemed a viable alternative approach. 
Gregg, Callaghan, Hayes, and Glenn-Lawson (2007) conducted an RCT 
within a diabetic population. Eighty-one participants were randomised to an ACT plus 
education group (n=43) or education group alone (n=38). The education group 
received advice on how to manage their diabetes better during a seven-hour 
workshop. The ACT group received an abbreviated version of the education (four-
hours) as well as mindfulness and acceptance training. The authors found that 
participants in the ACT group had significantly more control over their glucose levels 
compared to the controls. Furthermore, the ACT group scored better on self-
management which included self-reported items regarding diet, exercise and glucose 
monitoring. Finally, the ACT group scored higher on a diabetic measure of 
psychological flexibility compared to controls. In this study the fidelity to the 
treatment manual was not assessed and the ACT intervention was delivered by a 
single therapist. Furthermore, the self-management index did not represent a 
comprehensive set of behaviours which are pertinent to this population such as 
medication adherence, smoking, alcohol use, foot and eye care. 
Lillis, Hayes, Bunting, and Masuda (2009) undertook a RCT by randomly 
assigning 87 patients that had completed a six-month weight loss program. 
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Participants were randomised to a one-day ACT intervention (n=43) targeting obesity-
related stigma and psychological distress or a WLC (n=44). The ACT condition 
consisted of a single six-hour workshop in a group based format with participants also 
receiving a workbook to take away. After a three-month follow up the ACT group had 
significant improvements on all measures which included; psychological distress, 
QoL, weight-related stigma, body mass index and percentage weight loss. The study 
did have its weaknesses particularly with the sample being relatively homogenous as 
they were predominately white, middle-class, women, from the USA. The control 
group was a WLC which is not an appropriate control group as there is no active 
treatment. Lastly the adherence to the ACT interventions was not formally assessed. 
Weineland, Arvidsson, Kakoulidis, and Dahl (2012) investigated the utility of 
an ACT intervention with post-bariatric surgery patients suffering with morbid 
obesity. A total of 39 patients were randomised to either an ACT intervention (n=19) 
or TAU (n=20). The ACT group received two face to face sessions, a six-week 
treatment via the internet and a 30-min support session weekly over the telephone. 
The authors found that in the ACT group patients scored significantly lower on a 
measure of eating disorders behaviour which consists of four sub-scales; restraint, 
eating concerns, weight concerns and shape concerns. There was also a significant 
improvement in QoL and psychological flexibility as measured on the Acceptance and 
Action Questionnaire for Weight (AAQW) within the ACT group. The study did 
suffer with having a small sample size and short-term follow up of three-months 
considering the aim is long-term weight control. The study relied on self-reports when 
objective measures such as measuring weight or physical activity would have been 
more appropriate. The TAU group did not include an active treatment and therefore is 
not an appropriate control group. 
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1.4.2.3. Evidence from meta-analyses.    
The findings from the RCTs above provide promising evidence regarding the 
utility of ACT within a number of different populations. ACT has been investigated in 
a wide range of populations including psychiatric and somatic conditions. Many of the 
studies outlined above however do have a number of methodological concerns. The 
control groups in many of the trials have relied on WLC/TAU rather than offering a 
suitable alternative therapy which has a proven evidence base. Furthermore, studies 
have suffered with small sample sizes. There have been a number of M-As which 
have investigated the utility of ACT and evidence is presented below chronologically 
(A-Tjak et al., 2015; Öst, 2008, 2014; Powers, Zum Vörde Sive Vörding, & 
Emmelkamp, 2009; Ruiz, 2012; Veehof, Oskam, Schreurs, & Bohlmeijer, 2011). 
Statistics for ES are presented as Cohen‘s d and the interpretation of these statistics is 
based on the convention small, medium and large (.2, .5 and .8 respectively) as 
described by J. Cohen (1988). 
Öst (2008) conducted a M-A investigating the efficacy of ACT across a range 
of clinical presentations. He found a significant medium to large mean ES of, d = 
0.68, Z = 5.11, p < .001 based on primary outcomes reported in the RCTs. Primary 
measures included, anxiety, depression and pain. A test of heterogeneity, a measure of 
how far the observed ES differs from the true ES, was significant. Therefore further 
moderator analysis was conducted to interpret the reason for the observed range of 
ESs. Analysis of the control conditions revealed that ACT vs. WLC yielded a large 
ES whereas ACT vs. active therapy yielded a medium ES. Therefore studies that 
included a WLC rather than an active control would report larger ES. Öst (2008) does 
criticise the evidence base for ACT stating that methodologically it is inferior to 
evidence based approaches such as CBT. 
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Powers et al. (2009) analysed 18 RCTs totalling 917 participants utilising 
ACT across different presentations. They reported that compared to controls ACT was 
significantly superior with a reported small to medium ES, d = .42, on primary 
outcome measures. When analysed separately ACT was superior to WLCs and 
psychological placebos d = .68 and TAU d = .42. However, ACT was not 
significantly more effective than evidence-based treatments d = .18, p = 0.13. When 
investigating the utility of ACT across different populations the results were mixed. 
The authors reported that ACT was superior compared to controls across primary and 
secondary outcome measures. This conclusion was based on multiple M-As with only 
a few studies e.g., only two studies were used in the depression M-A. The researchers 
also state that a majority of studies utilise TAU which is not an appropriate control 
group due to the lack of an active treatment. 
Veehof et al. (2011) investigated the effectiveness of ACT within a chronic 
pain population utilising an M-A. The authors included 22 studies, nine RCTs, five 
control studies without randomisation and eight uncontrolled studies totalling 1235 
participants. The combination of both controlled and uncontrolled studies yielded a 
significant small to medium ES for ACT, d = .43, Z = 4.06, p < .01 for the primary 
outcome, pain. The combination of both controlled and uncontrolled studies yielded a 
significant medium to large ES for ACT, d = .63, Z = 3.58, p < .01 for the secondary 
outcome, QoL. The authors stated that only two studies met the criteria of high quality 
in their M-A again criticising the methodology used in these studies. 
Ruiz (2012) compared the relative effectiveness of ACT against CBT using a 
M-A. Sixteen studies totalling 954 participants across different populations (e.g., 
depression, anxiety disorders, smoking, cancer, stress) were included. Ruiz (2012) 
reported that the small to medium mean ES significantly favoured ACT compared to 
CBT based on primary outcomes, d = .40, Z = 3.23, p = .001. ESs for depression (d = 
.27), anxiety (d = .14) and QoL (d = .25) favoured ACT but were not statistically 
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significant. The M-A also investigated how well ACT and CBT affected their 
respective putative processes of change. ACT affected more on its processes of 
change (e.g., psychological flexibility) compared to CBT (e.g., cognitive 
restructuring) leading to the conclusion that ACT produces better outcomes and works 
through different processes than traditional CBT. The studies used in the M-A suffer 
with small sample sizes and methodological problems such as subclinical 
psychological problems and non-randomised trials. The use of varied populations may 
also provide ranging ESs as each therapy may be more or less effective in different 
populations.  
Öst (2014) conducted a large scale M-A including all the reported RCTs that 
have investigated the efficacy of ACT in any population (e.g., psychiatric disorders, 
somatic disorders and stress at work) since 1986 in order to update a previous M-A 
(Öst, 2008). 60 RCTs totalling 4234 participants were included. A small to medium 
ES was calculated across all comparisons, d = .42, Z = 7.47, p < .001 which was 
smaller than the previous M-A, d = 0.68, Z = 5.11, p < .001 (Öst, 2008). Öst (2014) 
concluded that ACT is not yet a well-established treatment for any disorder. 
Furthermore, that ACT is ‗probably efficacious‘ for chronic pain and tinnitus whereas 
it is ‗possibly efficacious‘ for depression, psychotic symptoms, OCD, mixed anxiety, 
drug abuse and stress at work; and that ACT is ‗experimental‘ for nicotine 
dependence, borderline personality disorder, trichotillomania, epilepsy, 
overweight/obesity, diabetes, multiple sclerosis and ovarian cancer based on 
additional analyses. Öst (2014) argues that the current evidence base of ACT is 
lacking in methodological quality which has not improved since his previous M-A 
and therefore many of the claims of its effectiveness or superiority (Ruiz, 2012) are 
unfounded. The conclusions made by Öst regarding the efficacy within this M-A was 
based on an unrestricted inclusion criteria resulting in a range of studies investigating 
sub-clinical populations. Utilising sub-clinical populations may also make it more 
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difficult to effectively measure change as participants would already be scoring at the 
lower level on measures. The inclusion of studies not treating clinically relevant 
disorders such as stress at work may have had an effect on the overall ES. 
Investigating all possible M-As that have utilised ACT makes the interpretations of 
the results much more difficult. The interpretation of the overall ES is relevant to all 
sub-groups and therefore it is not possible to separate out each clinical group. 
Furthermore, the assessment of methodological quality was conducted by the author 
and not cross checked to allow for investigation of the inter-rater reliability which 
may have introduced bias. 
A-Tjak et al. (2015) undertook an M-A of ACT for clinically relevant mental 
and physical health problems. 39 studies totalling 1,821 participants with mental 
disorders or somatic health problems were included. The authors concluded that ACT 
was superior to control conditions and reported a medium ES for primary outcome 
measures d = .54, p < .001. ACT was also superior to controls on secondary outcome 
measures (d = .30, p < .001), QoL (d = .37, p < .001) and process measures (d = .56, p 
< .001). As previously noted ACT was significantly better than WLC and TAU 
however ACT was not significantly better than established treatments such as CBT, d 
= .32, p = .140). A-Tjak et al. (2015) concluded that ACT outperformed control 
conditions for primary/secondary outcome measures, QoL and process measures. 
There was no significant difference between ACT and established treatments however 
the ES for ACT was slightly larger. The authors concluded that ACT therefore could 
be considered as an alternative to CBT within the populations under investigation. In 
contrast to Öst (2014), the authors reported a relative improvement in methodological 
quality over the years since the first Öst review (Öst, 2008) but did acknowledge that 
studies with greater quality reported smaller ESs.  
Following the publication of  A-Tjak et al. (2015), there has been 
correspondence between researchers (Hertenstein & Nissen, 2015; Morina, A-Tjak, & 
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Emmelkamp, 2015) regarding the contradictory findings between this M-A and Öst 
(2014). The correspondence highlighted the methodological issues pertaining to 
conducting a M-A and how selection of different procedures can result in different 
results. Morina et al. (2015) argued that the A-Tjak et al. M-A included stricter 
inclusion criteria invoving only clinically relevant populations (e.g., excluding studies 
investigating work stress). Secondly the statistics utilised intent-to-treat analysis and 
completer analysis separately where applicable, and a comparison of the differences. 
Thirdly, the rating of methodological quality was conducted by two of the authors to 
remove bias. Lastly, the criterion applied to examine the efficacy of ACT was based 
on the findings from the M-A and not the criteria for well-established treatments of 
the American Psychological Association (APA). The conclusions drawn by Öst 
actually contradict the assertions of the APA (Division of Society of Clinical 
Psychology) which state there is strong research support for using ACT in chronic 
pain and modest support in depression, mixed anxiety, OCD and psychosis 
(http://www.div12.org/psychological-treatments/treatments/).  
1.4.2.4. Summary of evidence. 
The evidence above highlights the growing research base for ACT and its 
potential utility across a number of varied populations. Research has predominately 
been conducted across psychiatric and somatic populations with promising findings. 
Furthermore, data from M-As conducted report ESs ranging from .40 to .68 which 
represent small to medium effects of ACT across a diverse population. It should be 
noted that despite these promising findings a number of concerns have been raised 
regarding the methodology of many studies. In summary these include the use of 
WLC and TAU as control groups instead of active treatments that have a recognised 
evidence base; and small sample sizes with unrepresentative participants some of 
whom do not have a formal diagnosis. There has been a debate about how issues such 
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as these have been addressed since they were first highlighted (A-Tjak et al., 2015; 
Hertenstein & Nissen, 2015; Morina et al., 2015; Öst, 2014). There will always be 
more room for well controlled high quality studies investigating the efficacy of any 
treatment program. This will go a long way to help make clearer the picture regarding 
the utility of ACT across a diverse population (S. C. Hayes et al., 2006). 
1.5. Rationale 
There is evidence to suggest that ACT may have potential in reducing 
psychological distress in a range of populations (A-Tjak et al., 2015; Öst, 2008, 2014; 
Powers et al., 2009; Ruiz, 2012; Veehof et al., 2011). However the sequelae of 
chronic health conditions can have a wide reaching effect on different areas such as 
QoL. The purpose of this current thesis is to investigate the efficacy of ACT on 
improving QoL in people who have chronic health conditions via a M-A. Based on 
the authors knowledge there does not appear to have been a previous review that has 
specifically investigated the efficacy of ACT in improving QoL in patients with 
chronic physical conditions. 
Previous reviews of ACT have concentrated on how symptoms such as anxiety 
and depression are improved. Mental health has predominately been viewed as the 
absence of psychopathologies such as anxiety and depression (Westerhof & Keyes, 
2010). The contemporary approach to understanding mental health has been more 
concerned with not just the absence of mental illness but also the presence of mental 
health (Friedli, 2009). Friedli (2009) further argues that people suffering with mental 
health difficulties should be taught psychological skills to help them cope with their 
suffering rather than focus on changing how they think which may or may not change 
their mood. This is especially pertinent within the ACT philosophy and the chronic 
health population which we know affects many aspects of functioning and well-being 
and not just mental health. 
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QoL was chosen as an outcome measure as it was considered to better reflect 
the effects of chronic health conditions compared to simply the presence of mental 
health difficulty. Chronic health conditions appear to be associated with reductions in 
physical, social and mental well-being and functioning. QoL is a multi-dimensional 
construct and possibly for this reason it has become an important clinical outcome 
measure within this population (Arnold et al., 2004). ACT proposes to improve 
psychological flexibility which is in the service of living a valued life. QoL has been 
shown to correlate with the AAQ and AAQ-II (Bond et al., 2011; S. C. Hayes et al., 
2006). Given the shortcomings of the AAQ and the relatively recent development of 
the AAQ-II and that it has not always been routinely used, QoL was chosen as an all-
encompassing outcome measure especially given its pertinence within this population. 
ACT may provide an alternative therapeutic approach which could potentially 
be suited within the chronic health population. ACT does not aim to reduce 
psychological distress, but acknowledges that this can be a by-product; instead it tries 
to improve flexibility with the aim of living a valued life. This approach resonates 
with the aims of treatment within the chronic health population and therefore may be 
an efficacious approach to improving the QoL. 
1.6. Research Questions 
The aim of this thesis is to review the efficacy of ACT for improving QoL in 
individuals with a chronic health condition, via a M-A. Secondary questions relate to 
investigating sub-groups analysis. 
Primary Research Question 
1. Is ACT an effective treatment in improving QoL for people with 
chronic health conditions? 
Secondary Research Questions 
2. Does study quality mediate changes in QoL? 
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3. Does treatment intensity (time) correlate with effect size? 
4. Does publication date correlate with effect size?  
5. Does the control group (WLC/TAU vs. active control) mediate 
changes in QoL? 
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 Chapter Two: Methodology 
2.1. Overview 
The following chapter outlines the methodology. It begins with a description 
of the inclusion and exclusion criteria which contains; participants, intervention, study 
design and outcomes. Next the search strategy is described followed by the procedure 
for data extraction, ES calculation and study quality assessment. Finally the process of 
the meta-analysis is described including how threats to internal and external validity 
will be investigated and addressed. 
2.2. Inclusion and Exclusion Criteria 
2.2.1. Participants. 
 Studies were included if the participants were 18 years or over. Studies with 
participants under the age of 18 were excluded unless the data could be separated in 
the analysis. Included participants must have been suffering from a chronic physical 
health condition. There is no universal agreed definition of ‗chronic health condition‘ 
and therefore there was a need for a clear definition that would be used in this study. 
The definition below was utilised in this research (O'Halloran et al., 2004). 
A chronic health condition was defined as a condition which has: 
a) A duration that has lasted, or is expected to last, at least six months 
b) A pattern of reoccurrence or deterioration 
c) A poor prognosis 
d) Consequences or sequelae that impact on the individual‘s quality of 
life 
45 
2.2.2. Intervention. 
Studies were included that utilised ACT as described by Steven Hayes (S. C. 
Hayes et al., 1999, 2011). Some researchers have described ‗acceptance-based‘ 
interventions which utilise the principles of ACT varyingly. Studies that have utilised 
an acceptance-based approach which have utilised only one or two components of 
ACT were excluded as has been the protocol in a recent M-A (Öst, 2014). This was to 
ensure the integrity of the intervention was maintained and that clear conclusions 
could be drawn about the efficacy of ACT per se rather than a derivative of the 
approach. ACT can be delivered 1:1 or as group therapy and should be administered 
by therapists with relevant experience. A number of protocols developed for different 
target populations are documented on the Association for Contextual Behavioural 
Science website (http://contextualscience.org/treatment_protocols), however ACT 
tends  not to follow a strict manualised approach but adheres to the principles outlined 
by Steven Hayes (S. C. Hayes et al., 1999, 2011). There is however a great emphasis 
on the need to adhere to its core principles which have been outlined in the 
introduction in section 1.4 (S. C. Hayes et al., 1999, 2011). Treatments administered 
only via self-help or over the internet were excluded to ensure treatment fidelity. 
2.2.3. Study design. 
Quantitative studies that were written in English were included. This included 
controlled studies that utilised a control or comparison group e.g., active control, 
WLC or TAU with or without randomisation. Uncontrolled studies were not excluded 
from this M-A as research into ACT is still developing. Single case series, case 
studies, and qualitative studies were excluded. Previous systematic reviews, M-A, or 
studies reporting previously published data were also excluded to avoid duplication of 
data (Senn, 2009). Studies that did not provide relevant information to calculate ESs 
were also excluded unless it was possible to gain data from the authors. 
46 
2.2.4. Outcome. 
The primary outcome measure was QoL. Within the literature there is a broad 
agreement that QoL is a multidimensional construct that encompasses the subjective 
experience of physical and psychosocial aspects of a person‘s life (Ali et al., 2010; 
McDowell, 2006; Speight et al., 2009). Studies were included if they utilised any self-
report measure that measured QoL pre and post intervention. Studies that utilised 
more than one measure of QoL were subjected to a selection process with the measure 
that was theoretically and psychometrically superior being selected. Studies that 
utilised only a single item measure of QoL (e.g., visual analogue scales) were 
excluded as they do not adequately measure the multifaceted construct of QoL (Cella, 
1994). 
2.3. Systematic Search Strategy 
2.3.1. Databases searched. 
The following psychological, medical, and allied health professionals‘ 
databases (PsychINFO, MEDLINE and CINAHL Plus) plus Google Scholar were 
searched, as well as the Cochrane Library: 
1. PsychINFO (1880s onwards) is an electronic abstracting and indexing 
database compiled by the American Psychological Association. It searches 
behavioural and mental health literatures and has more than 3.7 million 
records which are updated weekly. PsychINFO covers approximately 
2,562 journals, books and dissertations from more than 50 countries. 
2. MEDLINE (1946 onwards) is the leading electronic bibliographic database 
of articles in the life sciences, with a focus on biomedicine and health. It is 
compiled by the National Library of Medicine in America and has over 
24.6 million records from over 5,600 worldwide journals, with weekly 
updates. 
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3. CINAHL Plus (1937 onwards) is an electronic indexing database provided 
by EBOSCO Publishing. It searches literature related to nursing, allied 
health professionals, biomedicine and healthcare. There are over 4.2 
million records from approximately 5,015 journals. 
4. Google Scholar is a freely accessible web search engine that indexes the 
full text or metadata of scholarly literature across disciplines and 
publishing formats. It includes most peer-reviewed online journals across 
Europe and America‘s largest scholarly publishers. It has been estimated 
that Google Scholars database includes 160 million documents. 
5. The Cochrane Library is a collection of databases in medicine and other 
healthcare specialities provided by the Cochrane Collaboration. It hosts the 
collection of Cochrane Reviews, a database of systematic reviews and M-
As which summarise and interpret the results of research. The library aims 
to make the results of well-conducted controlled trials available and is a 
key resource in evidence-based medicine.  
2.3.2. Search terms. 
Articles were sought by combining key words, as summarised in Table 2.1. 
Search terms included UK and USA terminology and truncation. Studies 
published/completed after 1980 were included; following the development of ACT 
into a formalised therapy in the 1990s (S. C. Hayes et al., 1999). An age filter was 
also applied to ensure that only studies with participants aged 18 and over were 
included. 
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Table 2.1. 
Search Terms used for the Systematic Literature Search  
Category Search terms 
 
1. Target population 
 
 
2. Intervention 
 
 
3. Outcome data 
 
4. Research 
 
5. Search string 
 
 
Chronic OR Physical OR Medical OR Health OR Condition 
OR Disease 
 
Acceptance and commitment therapy OR Acceptance-Based 
OR ACT 
 
Quality of life OR Life-satisfaction OR Well-being 
 
Random* OR Trial OR RCT OR Study 
 
1 AND 2 AND 3 AND 4 
 
  
2.3.3. Additional searches. 
To ensure that the literature search was as comprehensive as possible a 
number of additional search strategies were used. The ancestry method was used to 
identify relevant articles from the reference lists of included studies based on the 
initial search; review articles references were also searched. Furthermore, key journals 
such as the Journal of Contextual Behavioural Science, the Journal of Psychosomatic 
Research, the British Journal of Health Psychology, Psychosomatic Medicine and 
Pain were searched with the term ‗Acceptance and Commitment therapy‘. The 
Association for Contextual Behavioural Science website 
(http://contextualscience.org/ACT_Randomized_Controlled_Trials) has a list of RCTs 
that have utilised an ACT protocol. The website was searched to identify if any 
studies were appropriate that had been missed by the initial search. Key researchers 
within the field were also contacted via email with a request to identify any relevant 
ongoing or unpublished research. 
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2.3.4. Initial study screening. 
The titles and abstracts of the studies were read to determine whether they met 
the inclusion criteria. In instances where further information was required the full text 
of the article was read. A Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses flow diagram (PRISMA; Liberati et al., 2009) has been included. The 
PRISMA diagram outlines; identification, screening, inclusion and exclusion of all 
articles throughout the process with clear justifications (see Section 3.2). 
2.4. Data Extraction 
Information was extracted from the research articles in a systematic format 
using a data extraction form (see Appendix A). Data that was difficult to interpret or 
missing was requested directly from the authors via email. Data extraction was 
completed by the primary researcher and checked for completeness and accuracy by 
the primary supervisor. Disagreements where they occurred were resolved following 
discussions. 
2.4.1. Effect sizes 
It was expected that researchers would use different measures of QoL (Speight 
et al., 2009). It was therefore important to have a standardised measure of ES to 
measure the effect of ACT on QoL across the studies. The decision was made to use 
the standardised mean difference (SMD) as a measure of ES. The SMD is a measure 
of the treatment effect in each study and is relative to the variability observed within 
that study (Borenstein, Hedges, Higgins, & Rothstein, 2011; Lipsey & Wilson, 2000). 
ESs (SMD) were calculated  using Hedges‘ g which is a conservative measure of ES 
based on Cohen‘s d and corrects for possible positive bias in studies with small 
sample sizes (J. Cohen, 1988; Hedges, 1981). The standard error and variance of g 
was calculated and interpreted based on the convention small, medium and large (.2, 
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.5 and .8 respectively) as described by J. Cohen (1988). Studies that utilised multiple 
comparison groups were subjected to a selection process. Primarily, active treatment 
groups were selected over WLC/TAU as they represented a better quality control 
group. All ESs were calculated with the Cochrane Collaboration Review Manager 
Software (RevMan Version 5.3, 2014). 
2.5. Study Quality Assessment 
When conducting a M-A it is important that the included research is of good 
methodological quality to ensure the integrity of the M-A. Included studies were 
screened to assess the methodological quality of the research. It has been 
recommended by PRISMA that a checklist or component approach is used rather than 
scales due to problems with reliability (Liberati et al., 2009). The NICE Quality 
Appraisal Checklist for Quantitative Intervention Studies (NICE, 2012) was used to 
assess study quality (see Appendix B). The NICE checklist allows for the appraisal of 
internal and external validity of both randomised and non-randomised trials. The 
checklist was completed for each study included in the M-A by the primary researcher 
and primary supervisor independently in order to check for reliability. Each study 
received a score based on 27 ratings. Two ratings were excluded because they were 
summary scores, therefore a total of 25 coded ratings were utilised for each included 
study. The inter-rater reliability was assessed using the Kappa statistic (Altman, 
1991).  
2.6. Meta-analysis 
2.6.1. Model. 
There are two ways in which a M-A can be conceptualised: fixed-effect and 
random-effects models (Borenstein et al., 2011). The fixed-effect model assumes that 
the studies included in a M-A are sampled from a population that has a fixed but 
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unknown ES. Therefore, sample ESs are expected to be homogeneous because they 
have been derived from the same population which has a fixed average ES. 
Consequently, any variation in the distribution of ES is thought to be the result of 
purely sampling error (Cohn & Becker, 2003; Lipsey & Wilson, 2000). 
The second method is the random-effects model, which assumes that 
population ESs vary randomly from study to study. In reality, and especially within 
psychological research, it can be argued that there is not always a common ES within 
a sample from the population (Field, 2003). The studies included in a M-A are 
thought to be each sampled from a distribution of population ESs that naturally vary 
in their average ES (Hedges & Vevea, 1998; Hunter & Schmidt, 2000), related to 
factors such as methods used and the context of the research (Cohn & Becker, 2003; 
Field, 2003; Hunter & Schmidt, 2000). Therefore, the studies included in a M-A can 
be thought of as being sampled from a ‗superpopulation‘ of possible effects and the 
overall ES is an estimate of the mean of the superpopulation‘s ES distribution. 
Depending on the choice of model used in the M-A there is a subtle variation 
regarding the statistical standpoint. The main difference is regarding the source of 
error that is accounted for. In fixed-effect models, there is within-study error which is 
the result of sampling studies from a population of studies. This error is present within 
random-effects models but, in addition, between-study error is also assumed as a 
result of sampling studies from individual sub-populations which make up the 
‗superpopulation‘. 
2.6.1.1.  Rationale for using a random-effects model. 
Following the recommendation by Borenstein et al. (2011) and Lipsey and 
Wilson (2000), a random-effects model was used here for two principal reasons. First, 
research within social sciences is inherently conducted by a range of researchers using 
a wide and varied array of methodologies which ultimately results in variability in 
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ESs as the norm (Borenstein et al., 2011; Field, 2003, 2005; Hunter & Schmidt, 
2000). It was expected that studies would differ regarding the intervention, diagnosed 
condition and outcome measures used. Secondly, the inferences made from a random-
effects model are relatively unconditional and may be applied to a population of 
studies larger than the sample. A fixed-effect model is appropriate for making 
inferences that extend to only the studies included in the analysis. Since social science 
researchers hope to extend their findings to subsequent research, including previous 
research, or research that may have not been included in the M-A a random-effects 
model is appropriate (Borenstein et al., 2011; Cohn & Becker, 2003; Hedges & 
Vevea, 1998; Hunter & Schmidt, 2000).  
2.6.2. Sensitivity analysis. 
The process of undertaking a M-A involves making various decisions about 
the choice of articles that are under review, and about the methods of analysis. It is 
important to ensure that findings are robust and not a result of the decisions made in 
the process of obtaining them (Deeks, Higgins, & Altman, 2011). Thus the M-A 
should be repeated under different assumptions and after different decisions to see 
how far the obtained findings are consistent. 
2.6.3. Heterogeneity assessment. 
As part of conducting a M-A there is an underlying aim to attempt to measure 
and control for heterogeneity. The two sources of variability, within-study and 
between-study, must be assessed for and their effect minimised to ensure the 
robustness of the M-A. Within-study variability is an ever present within a M-A as 
every study uses a different sample (Huedo-Medina, Sánchez-Meca, Marín-Martínez, 
& Botella, 2006). There are a number of factors which can affect between-study 
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variability such as participants, measures, treatment conditions, study designs and so 
on (Borenstein et al., 2011; Cohn & Becker, 2003; Field, 2003). 
2.6.3.1. The I2 statistic test. 
The I
2
 statistic was used to explore heterogeneity as it provides a measure of 
variability across studies that is due to heterogeneity rather than chance (Higgins & 
Thompson, 2002). The rational for using the I
2
 statistic compared to the Cochran Q 
test is the ability to quantify heterogeneity. Furthermore it provides a measure of the 
degree of inconsistency in the study‘s results and there is no reliance on the number of 
studies used in the analysis (Higgins & Thompson, 2002; Higgins, Thompson, Deeks, 
& Altman, 2003; Huedo-Medina et al., 2006). The following classifications were used 
to assess the level of heterogeneity; High (75%), Medium (50%) and Low (25%) 
(Higgins et al., 2003). 
2.6.4. Publication bias. 
Publication bias, or the ‗file drawer problem‘ (Rosenthal, 1979), describes the 
tendency for the dissemination of research to depend on results (Vevea & Woods, 
2005). Bias could possibly manifest itself if only those studies with significant results 
are published and all other studies are left unpublished. This situation could arise 
because researchers are less likely to write up and submit these studies, or because 
journal editors and reviewers are unlikely to publish them (Vevea & Woods, 2005). 
This would result in M-As over estimating the population ES, potentially leading to 
inappropriate conclusions. The results from a M-A are often used to make practical 
recommendations for medical or psychological interventions and therefore there is a 
need to address this bias. A number of authors have suggested strategies for 
eliminating or preventing publication bias in the long-term, as well as statistical 
methods for detecting and correcting for it (Vevea & Woods, 2005). 
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Publication bias has traditionally been assessed using funnel plots whereby 
ESs are plotted against sample sizes (Light & Pillemer, 1984). A skewed and 
asymmetrical plot may indicate a bias and a potential ‗file drawer problem‘ 
(Greenhouse & Iyengar, 2009; Rosenthal, 1979). In this scenario the fail-safe N 
(Rosenthal, 1991) has historically been the method used to assess the effect of bias. 
Funnel plots require a large number of studies ranging in sample size, suffer from low 
inter-rater reliability (Song, Hooper, & Loke, 2013) and bias is not the only source of 
asymmetry in plots (Egger, Smith, Schneider, & Minder, 1997). Different formulas 
for the fail-safe N can lead to varying estimations and they do not take into account 
heterogeneity and are more concerned with significance than ES (Becker, 2005). In 
light of the concerns, preliminary inspection of the forest plot was undertaken to see if 
there was a skew towards smaller studies having larger ESs.  
2.6.4.1. Orwin’s fail-safe N. 
Orwin‘s fail-safe N (Orwin & Boruch, 1983) allows the researcher to specify 
how many studies it would take to bring the ES down to the smallest effect deemed of 
substantive importance (i.e., clinical significance). If the resulting N is relatively small 
it would indicate a reason for publication bias (Borenstein et al., 2011). This method 
was used to assess for the presence of publication bias (see Section 3.4.3). 
2.6.5. Moderator variables. 
The purpose of a M-A is to determine the effect of a given treatment on a 
certain sample from the population (Borenstein et al., 2011). In this research the effect 
of ACT on QoL within a chronic health sample was investigated. The nature of 
synthesising research inevitably involves analysing studies that have a wide range of 
methodologies (Öst, 2008, 2014). This introduces into the M-A a range of variables 
that can affect what the researcher is interested in, the ESs. These variables are known 
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as moderator variables and can affect the strength and the direction of the ESs. 
Potential moderator variables include; overall study quality, study type (randomised 
vs. non-randomised), treatment intensity etc. Essentially, a moderator variable can be 
anything that could affect the strength and direction of the ES. The effect of 
moderator variables is described in the results section and explored later in the 
discussion section (see Section 3.4.2.1 and 4.2). 
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 Chapter Three: Results 
3.1. Overview 
The chapter begins with a detailed account of the outcome from the literature 
search including a PRISMA diagram. A description of the included/excluded studies 
and study quality is also provided. The findings from the within and between-group 
M-A which includes further sub-group analyses and assessment of publication bias 
are reported. The results chapter presents the findings from the M-A with the aim of 
answering the primary research question regarding the efficacy of ACT in improving 
QoL within a chronic health population. The findings from moderator analysis are 
outlined as part of the secondary research questions. 
3.2. Literature Search Outcome 
The literature search was completed on 23
rd
 April 2015 and yielded a 
preliminary database of 1081 articles from the electronic databases, Google Scholar 
and additional searches outlined in section 2.3 (see Figure 3.1). This initial pool of 
studies was reviewed (titles and abstracts) to determine eligibility. The full articles of 
potential studies were acquired and subjected to the inclusion and exclusion criteria 
(see Section 2.2) resulting in a final group of studies (see Figure 3.1 and Table 3.2). 
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Figure 3.1. PRISMA flow diagram. 
 
3.2.1. Included studies.  
Of the 1081 published studies 65 (6.01%) were identified for potential 
inclusion following the screening of the title and abstract. The majority of articles 
excluded during the initial screen included; books, book chapters, theses and review 
articles including M-As. A number of articles were not intervention studies and some 
studies utilised samples that did not include chronic health conditions. Following the 
full review 12 studies of the 1081 (1.11%) were included in the M-A based on 
meeting the inclusion and exclusion criteria. Studies included in the M-A are 
described in detail in Table 3.2.  
The 12 studies included in the M-A collectively investigated ACT with 788 
participants with a mean age of 46.7 years (SD = 11) with a range of 18 to 89. Studies 
were primarily controlled trials (83%) and used an active control group (n = 6) or 
Electronic database search results 
(including Google Scholar): n=937 
Additional search 
results: n=144 
Excluded studies following 
title and abstract screening: 
n=1016 
Provisionally included 
studies: n=65 
Excluded studies after 
screening full article: n=53 
 
No QoL measure n=13 
Not chronic health n=12 
Not ACT n=12 
Not quantitative n=8 
Replicated data n=4 
Child/adolescents n=2 
Not in English n=2 
Studies included in 
the M-A: n=12 
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WLC/TAU (n = 5). One study did not utilise a control group (Feros, Lane, Ciarrochi, 
& Blackledge, 2013) and one study was not randomised (Dindo, Recober, Marchman, 
Turvey, & O'Hara, 2012). The most common disorder studied was chronic pain (n = 
5) followed by cancer (n = 3). Eleven studies reported information on the hours of 
therapeutic contact (mean = 9.23, SD = 4.03) which ranged from 4 to 18. Eleven 
studies measured QoL after a follow-up period which ranged from 3 to 18 months 
post intervention (mean = 8, SD = 4.86). Eight different self-report measures were 
used to measure QoL and are reported in Table 3.1. All scales measuring QoL had 
either acceptable or good internal consistency (.7 to .9) as measured by Cronbach‘s 
alpha (Cronbach, 1951). 
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Table 3.1. 
Description of Quality of Life Measures 
Measure Description 
Internal 
Consistency 
(Cronbach’s α) 
FACT-C 
A measure of physical, emotional, 
functional and social well-being 
across four domains with additional 
questions related to colorectal cancer 
.84 
FACT-G 
A measure of physical, emotional, 
functional and social well-being 
across four domains 
.87 
LSQ 
A measure of physical health and 
social functioning across six domains 
.70 to .90 
QOLI 
A measure of general QoL, physical 
health and social well-being.  
.79 to .89 
SF-36 
A measure of physical, emotional, 
psychological and social well-being 
.79 to .93 
SF-12 
A measure of physical, emotional, 
psychological and social well-being 
with fewer items than the SF-36 
.81 to .84 
SWLS A measure of global life satisfaction .87 
WHOQOL-
BREF 
A global measure of QoL across four 
domains, physical health, 
psychological, social relationships 
and environment 
.81 to .90 
 
Note. FACT-C: The Functional Assessment of Cancer Therapy-Colorectal is from 
Ward et al. (1999); FACT-G: The Functional Assessment of Cancer Therapy-General 
is from Cella et al. (1993); LSQ: Life Satisfaction Questionnaire is from Carlsson, 
Hamrin, and Lindqvist (1999); QOLI: Quality of Life Inventory is from Frisch, 
Cornell, Villanueva, and Retzlaff (1992); SF-36: The Short Form-36 Health Survey is 
from Ware and Sherbourne (1992); SF-12: The Short Form-12 Health Survey is from 
(Ware, Kosinski, and Keller (1996); Ware, Kosinski, Turner-Bowker, and Gandek 
(2002)); SWLS: The Satisfaction With Life Scale is from Diener, Emmons, Larsen, 
and Griffin (1985); WHOQOL-BREF: The World Health Organization Quality of 
Life, short version is from Herrman et al. (1998). 
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Table 3.2. 
A Description of the Included Studies 
Study ID Diagnosis Group N
a
 
Mean 
age 
(SD) 
ACT 
intensity 
(minutes)
b
 
QoL 
measure 
Follow-
up 
(months) 
Between 
ES* 
Within ES 
(pre to 
post)* 
Within ES 
(post to 
follow-up)* 
Dahl et al. 
(2009) 
Chronic 
pain/Stress 
ACT 
TAU 
11 
8 
37.6 
44.4 
240 
LSQ 
 
6 .236 .122 -.163 
Dindo et al. 
(2012) 
Migraine 
ACT 
WLC 
31 
14 
32.5 
(13.3) 
33.5 
(12.9) 
240 SF-36 3 .661 .683 .427 
Feros et al. 
(2013) 
Cancer 
ACT 
- 
28 
51.8 
(18.3) 
405 FACT-G 3 
No 
Control 
group 
.547 -.037 
Hawkes et al. 
(2014) 
Colorectal 
Cancer 
ACT 
TAU 
171 
176 
- 
- 
- FACT-C 6 .183 
Unable to 
calculate 
.183 
Lundgren et al. 
(2006) 
Epilepsy 
ACT 
Attention 
placebo 
14 
13 
38.9 
42.5 
540 
WHOQ
OL-
BREF 
12 .355 .604 .929 
Lundgren et al. 
(2008) 
Epilepsy 
ACT 
Yoga 
10 
8 
21.9 
25.8 
540 
WHOQ
OL-
BREF 
12 -.364 .748 .168 
Rost et al. 
(2012) 
Ovarian 
cancer 
ACT 
CBT 
15 
16 
- 
- 
720 FACT-G - .960 .781 No follow-up 
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Study ID Diagnosis Group N
a
 
Mean 
age 
(SD) 
ACT 
intensity 
(minutes)
b
 
QoL 
measure 
Follow-
up 
(months) 
Between 
ES* 
Within ES 
(pre to 
post)* 
Within ES 
(post to 
follow-up)* 
Thorsell et al. 
(2011) 
Chronic pain 
ACT 
Relaxation 
33 
31 
- 
- 
390 SWLS 12 .741 .741 .540 
Westin et al. 
(2011) 
Tinnitus 
ACT 
TRT 
21 
18 
53.5 
(12.9) 
48.6 
(14.5) 
615 QOLI 18 .187 .242 .087 
Wetherell et al. 
(2011) 
Chronic pain 
ACT 
CBT 
49 
50 
- 
- 
720 SF-12 6 -.268 .151 -.064 
Wicksell et al. 
(2008) 
Whiplash/Ch
ronic pain 
ACT 
WLC 
11 
9 
48.2 
(7.8) 
55.1 
(11.2) 
600 SWLS 4 1.008 1.048 -.047 
Wicksell et al. 
(2013) 
Fibromyalgia
/Chronic 
pain 
ACT 
WLC 
20 
14 
- 
- 
1080 SF-36 3 .356 .330 .023 
 
Note. FACT-C: The Functional Assessment of Cancer Therapy-Colorectal; FACT-G: The Functional Assessment of Cancer Therapy-General; 
LSQ: Life Satisfaction Questionnaire; QOLI: Quality of Life Inventory; SF-36: The Short Form-36 Health Survey; SF-12: The Short Form-12 
Health Survey; SWLS: The Satisfaction With Life Scale; WHOQOL-BREF: The World Health Organization Quality of Life, short version 
 
TRT = Tinnitus Retaining Therapy 
 
*All ESs are presented as Hedge‘s g 
 
a 
N is based on the participants that had complete data and entered into the final analysis which may vary from the number participants recruited. 
 
b
 This is a measure of the total number of therapeutic time with participant‘s measured in minutes.  
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3.3. Study Quality 
Study quality was assessed by the primary researcher and independently by the 
primary supervisor using The NICE Quality Appraisal Checklist for Quantitative 
Intervention Studies (NICE, 2012). This method utilises a checklist approach (see 
Appendix B) therefore each rating was given a numerical score in order to calculate 
the inter-rater reliability using the Kappa statistic (Altman, 1991). A total of 300 
ratings were computed with each study scoring a potential maximum score of 50 
based on 25 possible ratings. The mean score across 12 studies was 32 (SD 6.16). The 
kappa statistic was calculated as, k = .73 which based on benchmarks indicates a 
‗good‘ level of agreement between raters (Altman, 1991). 
Overall the studies included in the M-A utilised reliable and valid measures of 
QoL. ACT interventions were described well but many studies did not utilise a 
treatment manual. A total of six studies utilised an active treatment as the control 
group (Lundgren, Dahl, Melin, & Kies, 2006; Lundgren, Dahl, Yardi, & Melin, 2008; 
Rost, Wilson, Buchanan, Hildebrandt, & Mutch, 2012; Thorsell et al., 2011; Westin, 
Schulin, Hesser, & Karlsson, 2011; Wetherell et al., 2011) and five studies utilised a 
WLC/TAU control group (Dahl, Wilson, & Nilsson, 2004; Dindo et al., 2012; 
Hawkes, Pakenham, Chambers, Patrao, & Courneya, 2014; Wicksell, Ahlqvist, Bring, 
Melin, & Olsson, 2008; Wicksell et al., 2013). There was limited data on therapist 
ratings and treatment adherence. Many studies were underpowered (Dahl et al., 2004; 
Lundgren et al., 2006; Lundgren et al., 2008; Rost et al., 2012; Thorsell et al., 2011; 
Wicksell et al., 2008; Wicksell et al., 2013). Of the studies included in the M-A, five 
studies (Dahl et al., 2004; Feros et al., 2013; Lundgren et al., 2006; Lundgren et al., 
2008; Rost et al., 2012) scored below the median rating of 31. 
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3.4. Findings from the Meta-Analysis 
The following section reports the results of the M-A. Prior to reporting these 
statistics it is important to clarify that some SMD calculations of Hedge‘s g required 
additional analysis before the SMDs could be calculated (Dindo et al., 2012; Hawkes 
et al., 2014; Rost et al., 2012; Wetherell et al., 2011; Wicksell et al., 2013). 
Wetherell et al. (2011) and Wicksell et al. (2013) utilised the Short-Form 
Health Survey (SF-36 and SF-12) which produces two summary scores, the physical 
component summary (PCS) and the mental component summary (MCS) (Ware et al., 
1996; Ware & Sherbourne, 1992). A decision was made to combine the PCS and 
MCS scores to create a new total score which would then provide a mean and SD to 
enable the calculation of the SMD. The rationale and justification for this is that the 
SF-36 and SF-12 both measure fundamental aspects of QoL such as psychological, 
emotional, social and physical well-being (Ware et al., 1996; Ware & Sherbourne, 
1992). Furthermore, research has demonstrated that the underlying factor structure 
(PCS and MCS) within the SF-36 and SF-12 is correlated (r = .98 to .97) and 
therefore is measuring the same latent variable (Farivar, Cunningham, & Hays, 2007). 
Finally, a study already included in this review, has also combined the PCS and MCS 
scores as they report a SF-36 total score (Dindo et al., 2012). It was therefore deemed 
appropriate to combine these scores in order to compute the SMD. There was a need 
to compute a pooled SD and therefore a mean SD was computed which slightly 
underestimates the true SD. The result of this is a slightly inflated SMD as the SD is 
underestimated. The estimation of the SD in principle will only be slightly smaller 
than the true SD and therefore the practical effect on the size of the SMD would be 
minimal. 
Secondly, Hawkes et al. (2014) did not report means and SD for QoL and 
instead only reported mean change scores and the standard error (SE). It was therefore 
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necessary to compute the SD and calculate the SMD based on mean change scores. A 
calculation of the SD was completed using the method described in the Cochrane 
Handbook for Systematic Reviews of Interventions (Higgins & Green, 2008). 
Furthermore, a calculation of the SMD was based on the calculation provided by 
(Lipsey & Wilson, 2000). There was a need to include the test re-test reliability of the 
of the QoL measure from the study to calculate the SMD however this was not 
reported in the Hawkes article. Bausell and Li (2002) recommend that a conservative 
approach should be taken and that a reliability of .6 should be used which was 
included in the calculation. 
Thirdly, two studies reported only the SE and not the SD for QoL (Dindo et 
al., 2012; Rost et al., 2012). Therefore a calculation of the SD was conducted as 
outlined in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 
& Green, 2008). 
Lastly, Feros et al. (2013) was not a RCT and a control group was not used in 
the design. Since this was the only study in the M-A that did not include a control 
condition it was decided to remove this study from the overall between-group M-A 
but to include the results in the within-group M-A. 
3.4.1. Within-group M-A. 
A total of 11 studies reported data to calculate within-group pre to post ESs 
and were investigated in order to answer the primary hypothesis. One study did not 
report any follow up data (Rost et al., 2012) and another did not report statistics to 
calculate a pre to post ES (Hawkes et al., 2014). ESs were calculated for participants 
that received the ACT intervention only. This involved isolating the pre, post and 
follow-up data for individuals that completed the active ACT treatment condition. 
Data from 11 studies reporting the pre to post outcomes on QoL were included 
in a random-effects M-A, it was not possible to calculate the ES for one study 
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(Hawkes et al., 2014). A small to medium significant ES, g = .49, Z = 5.59, p < .001 
(95% CI [0.32, 0.67]) was found for pre to post ES (see Figure 3.2). The test of 
heterogeneity was not significant, I
2
 = 0%, p = .52, indicating that there was no 
significant inconsistency across the studies. This result indicates that people who 
receive ACT improve on measures of QoL in this M-A. 
Data from 11 studies reporting the post to follow-up outcomes on QoL were 
included in a random-effects M-A, one study did not conduct any follow-up 
assessments (Rost et al., 2012). A significant ES, g = .17, Z = 2.32, p < .02 (95% CI 
[0.03, 0.31]) was found for post to follow-up ES (see Figure 3.3). The test of 
heterogeneity was not significant, I
2
 = 0%, p = .52, indicating that there was no 
significant inconsistency across the studies. This result indicates that the treatment 
effects for ACT are enduring and that participants who undergo ACT will maintain 
improvements in QoL in the longer-term in this M-A. 
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Figure 3.2. Forest plot: M-A within-group pre vs. post treatment. 
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Figure 3.3. Forest plot: M-A within-group post vs. follow-up treatment. 
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3.4.2. Between-group M-A. 
A total of 11 studies compared ACT with a control group and were initially 
investigated together in order to answer the primary hypothesis. One study compared 
ACT to two different control groups, a WLC and an active control group (Westin et 
al., 2011). It was decided to include only the active control data (Tinnitus retraining 
therapy) from this study in the analysis as this is a better control condition. The WLC 
data from this one study was removed from the analysis to ensure that the study was 
not included twice in the M-A. Furthermore, as previously stated, one study did not 
have a control group and was not included in this analysis (Feros et al., 2013). 
ACT led to greater improvements in QoL across all controlled studies. A small 
to medium significant ES of, g = .33, Z = 2.57, p = .01, (95% CI [0.08, 0.58]) was 
found (see Figure 3.4). A measure of between-study heterogeneity (Tau
2
 = 0.08) was 
small indicating that between-study variance is low. The test of between-study 
heterogeneity was significant, I
2
 = 50%, p = .03. Further sub-group analysis were 
justified as the ESs were not consistent between studies with the I
2 
statistic reporting a 
‗moderate level‘ of heterogeneity (see Figure 3.2) (Higgins & Thompson, 2002; 
Higgins et al., 2003). 
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Figure 3.4. Forest plot: M-A between-groups post treatment. 
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3.4.2.1. Sub-group analysis. 
In order to investigate possible moderating variables, correlation and sub-
group analysis was used to investigate the relationship between ES and study quality, 
treatment intensity (time), publication date, and type of control group (WLC/TAU vs., 
Active). 
3.4.2.1.1. Study quality. 
An analysis of the relationship between ES and study quality was conducted. 
Pearson‘s correlation coefficient r was used to test the relationship, r(10) = -.13, p = 
.690 (two-tailed). This finding indicates that there was no significant relationship 
between study quality and ES.  
3.4.2.1.2. Treatment intensity. 
An analysis of the relationship between the ES and the amount of therapy 
offered in the ACT group was conducted. Pearson‘s correlation coefficient r was used 
to test this relationship, r(9) = .02, p = .953 (two-tailed). This finding indicates that 
there was no significant relationship between the amount of therapy offered and the 
ES. 
3.4.2.1.3. Publication date. 
An analysis of the relationship between the ES and the publication date of the 
study was conducted as it has been suggested this can mediate the ES (Light & 
Pillemer, 1984). Pearson‘s correlation coefficient r was used to test this relationship, 
r(10) = .32, p = .311 (two-tailed). This finding indicates that there was no significant 
relationship between the publication date and the ES. 
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3.4.2.1.4. Type of control group. 
Two further random-effects M-As were conducted to determine the effect of 
type of control group on the ES (see Figure 3.5 and 3.6). A decision was made to 
combine WLC and TAU based on the rationale that TAU is still offered to people 
(i.e., consultations, medication, advice etc.) when in a WLC and that there is 
substantial ambiguity and overlap in these two types of control groups in the literature 
(Freedland, Mohr, Davidson, & Schwartz, 2011). An active control was used as a 
control group in six studies whereas WLC/TAU was utilised in five studies.  
A small to medium significant ES, g = .32, Z = 2.11, p = 0.04 (95% CI [0.02, 
0.62]) was found when ACT was compared to studies that utilised a WLC/TAU 
control group (see Figure 3.5). The test of heterogeneity was not significant, I
2
 = 27%, 
p = .24; thus there was no significant inconsistency across the studies. 
A small non-significant ES, g = .27, Z = 1.19, p = 0.23 (95% CI [-0.17, 0.72]) 
was found when ACT was compared to studies that utilised an active control group 
(see Figure 3.6). The test of heterogeneity was significant, I
2
 = 67%, p = .01, 
indicating a substantial level of heterogeneity. 
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Figure 3.5. Forest plot: M-A, ACT vs. WLC/TAU. 
 
Figure 3.6. Forest plot: M-A, ACT vs. Active control. 
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3.4.3. Publication bias. 
In order to assess for publication bias a preliminary inspection of the forest 
plot was undertaken (see Figure 3.2). Two studies (Rost et al., 2012; Wicksell et al., 
2008) reported large ESs and also had small sample sizes. Orwin‘s fail-safe N was 
calculated (Orwin & Boruch, 1983). Analysis revealed that seven studies, with an ES 
of g = .0, or a negative value, would be needed to overturn the obtained mean ES (g = 
.33) to a small ES of less than, g = .2. As this number (k = 7) is relatively small the 
results cannot be considered robust to the effects of publication bias. For further 
discussion of the implications of this finding see section 4.5.2. 
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 Chapter Four: Discussion 
4.1. Overview 
The chapter begins with a summary of the findings from the M-A and sub-
group analysis in relation to the research hypotheses. The theoretical and clinical 
implications of the research findings are considered. The methodological strengths 
and limitations of the study are reflected on with suggestions for future research and 
concluding remarks.  
4.2. Summary of Main Findings 
4.2.1. Research question 1: Is ACT an effective treatment in improving 
QoL for people with chronic health conditions? 
The results from the within-group M-A revealed that participants suffering 
with a chronic health condition that received ACT significantly improved on measures 
of QoL with a small to medium ES (g = .49, p < .001). Next a between-groups M-A 
revealed that participants suffering with a chronic health condition that received ACT 
significantly improved on measures of QoL compared to controls with a small to 
medium ES (g = .33, p = .01 ). Furthermore, a within-group M-A revealed that 
improvements post treatment were maintained at follow-up in the ACT group (g = 
.17, p < .02). The results from these three M-As together indicate that ACT is an 
efficacious intervention at improving scores on measures of QoL within a chronic 
health population at post treatment compared to controls and that improvements are 
maintained longer-term. Orwin‘s fail-safe N was calculated to assess for publication 
bias. A score of seven indicates that the results from this M-A cannot be considered 
robust to the effects of publication bias. A test of between-study heterogeneity in the 
between-groups M-A was significant, I
2
 = 50%, p = .03 and therefore further sub-
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group analyses were conducted to explore for moderator variables which are 
discussed in sections 4.2.2 to 4.2.5. 
4.2.2. Research question 2: Does study quality mediate changes in QoL? 
The analysis of the relationship between ES and study quality revealed no 
significant relationship, r(10) = -.13, p = .690 (two-tailed). Therefore study quality is 
not a mediator of ES in this M-A. The moderate level of heterogeneity reported in the 
between-groups M-A cannot be explained by differences in study quality. 
4.2.3. Research question 3: Does treatment intensity (time) correlate with 
effect size? 
The analysis of the relationship between ES and amount of therapy offered 
revealed no significant relationship, r(9) = .02, p = .953. Therefore the intensity of 
treatment is not a mediator of the ES in this M-A. The moderate level of heterogeneity 
reported in the between-groups M-A cannot be explained by differences in treatment 
intensity. 
4.2.4. Research question 4: Does publication date correlate with effect 
size? 
The analysis of the relationship between ES and publication date revealed no 
significant relationship, r(10) = .32, p = .311. Therefore publication date is not a 
mediator of the ES in this M-A. The moderate level of heterogeneity reported in the 
between-groups M-A cannot be explained by when a study was published. 
4.2.5. Research question 5: Does the control group (WLC/TAU vs. active 
control) mediate changes in QoL? 
The results from comparing the type of control group (WLC/TAU or active 
control) revealed a significant ES for ACT vs. WLC/TAU group (g = .32, p = .04) but 
76 
not for ACT vs. active control group (g = .27, p = .23). This finding is congruent with 
results from previous M-As regarding the superiority of ACT compared to WLC/TAU 
(A-Tjak et al., 2015; Öst, 2008, 2014; Powers et al., 2009; Veehof et al., 2011). The 
small non-significant ES for ACT vs. active control underlines that within this sample 
of studies ACT was not significantly better at improving scores on QoL compared to 
an active control. Previous M-As (A-Tjak et al., 2015; Powers et al., 2009) have also 
reported similar findings regarding different outcomes. The moderate level of 
heterogeneity reported in the between-groups M-A to some extent could be explained 
by the type of control group. The implications of this finding are discussed below. 
4.2.5.1. ACT compared to active treatment. 
In the present M-A the finding that ACT was significantly better than 
WLC/TAU and not significantly better than an active treatment presents a confusing 
picture regarding the efficacy of ACT. Especially when taken in the context of a 
previous M-A which found ACT to be significantly better at improving outcomes 
compared to CBT (Ruiz, 2012). 
The active control groups in the M-A include a range of treatments and some 
which were not appropriate comparison groups. In the current review six studies 
utilised an active treatment condition and three studies utilised an evidence based 
approach (Rost et al., 2012; Westin et al., 2011; Wetherell et al., 2011). Lundgren et 
al. (2006) utilised an attention placebo as the control group and Lundgren et al. (2008) 
utilised yoga in the treatment of epilepsy both of which are not evidenced based 
treatment options. Furthermore, Lundgren et al. (2008) accepted that there was 
crossover between their two groups regarding the themes of the intervention in the 
treatment of epilepsy. It should be noted that at pre-treatment the active control group 
had a higher mean score compared to the ACT group at baseline which remained high 
at post treatment. This is despite the rate of mean improvement being greater in the 
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ACT group (5.9 vs. 1.3). A Cochrane review has also reported inconclusive evidence 
for the efficacy of yoga in the treatment of epilepsy (Panebianco, Sridharan, & 
Ramaratnam, 2015).  Thorsell et al. (2011) utilised applied relaxation as a treatment 
control for chronic pain, although relaxation has been used as a supplementary 
treatment in pain management programmes, previous research has found inconclusive 
evidence that it is an efficacious treatment in chronic pain (Henschke et al., 2010; 
Seers & Carroll, 1998; van Middelkoop et al., 2011). Of the three evidence based 
approaches only Wetherell et al. (2011) reported an ES (g = -.268) in favour for the 
control treatment (CBT). Interestingly, Rost et al. (2012) also utilised CBT for the 
control condition but reported a large ES in favour for ACT, g = .960. 
Participants in the studies included in the M-A would not have been selected 
based on a pre-treatment score of QoL, this was not an explicit target for treatment 
and therefore it was not a criterion for inclusion in the study (i.e., a low cut-off score 
for QoL). There was one study which investigated QoL as a primary outcome 
(Wicksell et al., 2008) which reported the largest ES (g = 1.008). This may, to some 
extent, explain why larger ESs were not reported regarding QoL in some studies. 
Elsewhere ESs have been reported for both primary and secondary outcomes that 
range between small and large (A-Tjak et al., 2015; Öst, 2008, 2014; Powers et al., 
2009; Ruiz, 2012; Veehof et al., 2011). With QoL not identified as a primary outcome 
in the studies, the magnitude of improvement in this outcome may not have been as 
large. Considering the importance of QoL in this population it may be appropriate to 
use QoL levels during recruitment as an inclusion/exclusion criterion and as a target 
for treatment. The results from this M-A may therefore suffer from a ceiling effect as 
lower scores of QoL would not have been one of the inclusion criteria in the studies. 
Therefore the magnitude of ESs may have been compromised resulting in the finding 
of much lower ESs. 
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In short, although the results indicate that ACT was not more effective when 
compared to an active control group, this finding should be treated with caution. A 
relatively small number of studies (k = 6) was used to calculate the effect of active 
control groups. Of the six studies included, four reported treatment effects in favour of 
ACT (Lundgren et al., 2006; Rost et al., 2012; Westin et al., 2011; Wetherell et al., 
2011) and three utilised an evidence based approach. Additionally, QoL was a 
primary outcome measure in only one study (Wicksell et al., 2008). Therefore, the 
finding that ACT is not more effective compared to an active treatment condition 
needs further investigation before a definitive conclusion can be drawn. 
4.3. Theoretical Implications 
The findings from the present study lend support to the claim that treatment 
with ACT within a chronic health population does lead to increases in QoL when 
compared to controls. This finding provides support to the underlying theoretical 
understanding of ACT. ACT is based on RFT which is grounded in FC (see Section 
1.4.1). RFT asserts that learning can occur without direct experience based on the 
inherent human ability of language through derived relationships, relational networks 
and transformation of functions. The aim of ACT has been to change the function of 
private experiences rather than their form/content (S. C. Hayes et al., 1999), which is 
the primary aim of CBT (Beck, 1979). There is a clear differentiation between 
traditional CBT and ACT in what is understood to lead to change. Both approaches 
rely heavily on behavioural techniques, as both approaches are derived from 
behaviourism, to implement change however the rationale is different. CBT asserts 
the use of cognitive restructuring and behavioural activation with the aim to challenge 
thoughts and change emotions. This is contrasted with ACT which aims to change the 
function and context in which private experiences occur rendering them less 
important. There is a growing evidence base for the underlying theoretical principles 
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of ACT. Levin, Hildebrandt, Lillis, and Hayes (2012) report the findings from a M-A 
which included 66 laboratory studies that have investigated the processes within the 
ACT model. The authors reported significant positive ESs for the individual 
components of the ACT model and supplementary analysis reported support for 
psychological flexibility. This is in contrast to the assertions made by CBT where 
improvements in outcome can occur despite no cognitive restructuring (Longmore & 
Worrell, 2007). CBT has a large evidence base however the notion that cognitive 
change is a necessary for clinical improvement is not well evidenced. Dobson and 
Khatri (2000, p. 913) have argued that there is ―no additive benefit to providing 
cognitive interventions in cognitive therapy‖. Furthermore the initial response to CBT 
has been suggested to occur prior to the implementation of cognitive restructuring 
(Ilardi & Craighead, 1994). It would suggest that positive clinical improvements 
following CBT may not occur through the proposed methods of change outlined in the 
model and therefore there is a need for further investigation as to what the 
mechanisms of change are in CBT. ACT however has a clearer theoretical standpoint 
and one which is evidence based. Nevertheless when examining the relative 
effectiveness of CBT and ACT in this M-A, no consistent differences emerged. 
With regards to the ACT model (S. C. Hayes et al., 1999) an increase in QoL 
can be explained as an increase in acceptance and a reduction in experiential 
avoidance, which can be ultimately described as an increase in psychological 
flexibility. The acceptance of private experiences which cannot be controlled allows 
the ability to focus and put energy into clarifying and pursuing meaningful values. 
This makes life more meaningful and worth living (Harris, 2006, 2009). As private 
experiences no longer hold a person back from engaging in life this can lead to an 
increase in QoL despite, in some circumstances, the persistence of physical 
symptoms. The treatment approach therefore relies on changing the function and 
context of private experiences. This is not to say that participants did not continue to 
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experience painful private experiences. The conclusion is that participants were able 
to, based on RFT, distance themselves from painful thoughts and accept 
emotions/physical pain when in the context of living a meaningful life in line with 
their values. In addition, ACT claims to be a transdiagnostic approach to human 
suffering (Harris, 2009). The current M-A reported on 12 studies within a diverse 
chronic health population and found that all studies reported improvements in QoL 
from pre to post-treatment following ACT. This provides further support for RFT 
regarding the function and context of private experiences rather than their form. 
Despite different chronic health conditions resulting in different forms of private 
experiences participants reported improvements in QoL following ACT. This 
underpins the notion that psychopathology from the RFT perspective is linked to 
human language and cognition (S. C. Hayes et al., 2006). 
4.4. Clinical Implications 
Within the chronic health population the primary approach traditionally has 
been to improve or manage medical symptoms including psychological distress (e.g., 
anxiety and depression). Progressively, improvements in QoL have become an 
important factor and now improving QoL is seen as an important outcome 
(Department of Health, 2012, 2015).  Psychological interventions have increasingly 
become central in attempting to improve QoL. The findings from this M-A suggest 
that ACT can improve QoL within a chronic health population and that these 
improvements are maintained at follow-up. ACT may therefore be an alternative 
treatment option for clinicians when working within this population. 
The effectiveness of psychological interventions have traditionally been based 
on how participants scores improve on measures of anxiety and depression (Öst, 
2008). These outcome measures may not be as salient within this population 
compared to QoL. The rationale for this is that patients may continue to experience 
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distress as part of their condition but what bearing does this have on their QoL? Based 
on the treatment philosophy of ACT, participants learn to live with painful private 
experiences whilst in the pursuit of a meaningful life (S. C. Hayes et al., 1999). 
Furthermore, the absence of psychological distress does not equate to well-being or 
necessarily improved mental health (WHO, 1947).  Improvements therefore in a 
multidimensional construct such as QoL highlight how ACT could help to improve a 
person‘s life despite suffering with a chronic health condition. 
With the rise in popularity of third-wave behavioural approaches such as ACT 
there is a need to consider how outcomes are measured and what important outcomes 
are for patients. This is particularly pertinent within the chronic health population 
where learning to live a valued and meaningful life whilst suffering with a chronic 
health condition is of great importance (Dysvik, Sommerseth, & Jacobsen, 2011), 
especially when considering that, despite all other interventions, the primary condition 
will remain or even deteriorate. The implication for clinical practice is therefore to 
include measures of QoL to measure treatment outcome. 
There continues to be pressure on the NHS to provide a quality service of 
healthcare whilst trying to keep costs down especially concerning long-term 
conditions (Department of Health, 2015; Naylor et al., 2012). Of the studies included 
in this M-A a range of different study designs and therapists were utilised when 
carrying out the ACT intervention. This included ACT groups, 1:1 therapy, telephone 
support, and intensive one day workshop groups. Furthermore, therapists from a range 
of backgrounds were included such as clinical psychologists, trainee clinical 
psychologists, CBT therapists, nurses, psychology interns and a physician. There have 
also been a number of internet and self-help protocols that have been evaluated 
(Buhrman et al., 2013; Gregg et al., 2007; Hesser et al., 2012; Johnston et al., 2010; 
Trompetter, Bohlmeijer, Veehof, & Schreurs, 2015). ACT has therefore been 
delivered in a number of different ways. The finding that there was no significant 
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relationship between treatment intensity and ES would suggest that ACT is just as 
effective in this population over long and short treatment protocols. ACT may 
therefore be a cost effective treatment within this population which would have a 
significant effect on clinical services. At present there is no formal certification 
required for therapists to practice ACT and there are a number of different ways that 
skills can be taught, via books, DVDs, peer consultation groups, special interest 
groups and conferences (https://contextualscience.org/act_certification). This would 
allow the rapid and widespread delivery of a treatment intervention which has been 
shown to have promising results regarding the improvement of a key outcome in 
chronic health. Despite this, there is also the reasonable counter argument that if 
services are already set up to offer treatments such as CBT, which have a strong 
evidence base, what benefit is there in changing to offer ACT? A greater 
understanding of what makes ACT and CBT effective, and if this differs, may help to 
clarify this debate and allow consideration of which approach would be most 
appropriate (S. C. Hayes et al., 2006; Levin et al., 2012; Longmore & Worrell, 2007). 
The majority of studies included in the M-A investigated a chronic pain 
sample (k = 5) however the included studies used a diverse population including 
patients suffering from epilepsy, various cancers, tinnitus and migraine. There is 
therefore a clinical dilemma when considering the findings from this M-A in isolation 
in deciding whether a service should adopt ACT for their client group. The strongest 
evidence for ACT is within a chronic pain population 
(http://www.div12.org/psychological-treatments/treatments/) which is also the most 
researched population (https://contextualscience.org/state_of_the_act_evidence). 
There is also the problem that QoL scores at pre-treatment in this M-A were varied. 
Thus the relative effect ACT has on QoL regarding different condtions is unclear. The 
purpose of ACT is to improve psychological flexibility. ACT is concerned with 
changing the relationship someone has with their thoughts and feelings in the context 
83 
of living a meaningful life. QoL is a broad multidimensional construct that measures 
psycholoigcal, social and physical factors and it could be that ACT effects change 
more so on the psychological element of QoL. As such, those particpants whose 
difficulties are within this construct of QoL may have reported greater gains from 
ACT. The measures of QoL may also not have tapped into other psychological parts 
of QoL which have been deemed important such as existential/spiritual QoL (S. R. 
Cohen, Mount, Tomas, & Mount, 1996). There is also the potential for a ceiling effect 
as samples may not have been recruited based on ‗clinical‘ scores of QoL which could 
affect the magnitude of ESs. Further investigation would be needed to consider how 
effective ACT is across sub-samples of this population.  
4.5. Strengths and Limitations 
4.5.1. Strengths. 
The current M-A, to the authors knowledge, is the first M-A to examine the 
efficacy of ACT in improving the QoL in patients suffering from chronic health 
conditions. ACT has an ever growing evidence base and proposes to be a 
transdiagnostic treatment which has been utilised in a number of different populations 
(Öst, 2014). Researchers have reported contradictory findings regarding the efficacy 
of ACT within different populations and between different treatment controls (A-Tjak 
et al., 2015; Öst, 2008, 2014; Powers et al., 2009; Ruiz, 2012; Veehof et al., 2011). It 
was therefore important to try to understand this confusing picture by conducting a 
systematic appraisal of the literature and providing evidence in the form of an M-A. 
The research is still, relative to CBT, in its early stages however this M-A does 
provide some insight in the potential utility of ACT within the chronic health 
population.   
In order to minimise bias during the literature search, and selection of 
publications, a clearly defined set of inclusion and exclusion criteria were utilised. It 
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is important to ensure that the initial search is comprehensive and therefore a number 
of electronic databases were utilised. Manual searching of key journals and reference 
lists of included studies were also conducted. Furthermore, a PRISMA diagram 
outlined the process involved in finalising the pool of included studies with clear 
reasons for the exclusion of studies. The studies were then scrutinised with a quality 
checklist which was rated by the primary researcher and independently by the primary 
supervisor to allow for assessment of the inter-rater reliability to minimise bias. An 
attempt was also made to gather present, ongoing and unpublished research by 
contacting prominent researchers in the field based on the literature search. 
There is a need to ensure that a M-A has a clear set of criteria regarding the 
types of research that should be included in the analysis. The current M-A had clearly 
defined criteria regarding participants, intervention, study design and outcomes. A 
well-defined definition of chronic health conditions and QoL was also utilised to 
ensure that only studies that reported on this were included. The focus on studies that 
utilised ACT increases the validity of the findings as some allegedly ACT research 
incorporate ‗mindfulness-based‘ approaches such as mindfulness-based stress 
reduction and mindfulness-based cognitive therapy. To ensure the fidelity of the 
treatment approach and increase the generalisability of the results a decision was 
made to exclude studies that only used self-help or internet based approaches. 
4.5.2. Limitations. 
The current M-A included a total of 12 studies in the analysis. This is a 
relatively small number of studies compared to previous analyses (Öst, 2014). A 
potential reason for the small number of studies could be explained in terms of the 
inclusion and exclusion criteria. The current M-A was investigating a narrow field of 
research into QoL in chronic health with ACT which, in relative terms when 
compared to established treatments such as CBT, is still very much in its infancy. A 
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number of publications had investigated ACT within chronic health; however many 
studies were excluded as there was no measure of QoL. As such, there may not yet be 
the volume of research available to conduct a large M-A with the criteria utilised in 
this study. This also constrains the approach that can be taken when considering the 
inclusion of studies as a number of studies had inadequate power. A Cochrane review 
recommended the removal of underpowered studies when a rapid analysis is required 
(e.g., when conducting time limited reviews in preparation for NICE guidelines) as 
they add little value to the overall M-A if several large RCTs have already been found 
(R. M. Turner, Bird, & Higgins, 2013). The current M-A included all studies which 
met the criteria and did not exclude smaller studies because, given the limited 
research base, it was important to include as many studies as possible especially when 
the aim is to resolve scientific uncertainty and investigate between-study 
heterogeneity (R. M. Turner et al., 2013). The result of having a small number of 
studies with small sample sizes is that it can affect the overall precision of the M-A. 
Nevertheless there are no definitive guidelines that specify a minimum number of 
studies or the particular number of participants that should be included in order to 
conduct a M-A (Borenstein et al., 2011; Valentine, Pigott, & Rothstein, 2010).  
The current M-A included a relatively small number of studies which can lead 
to a reduction in statistical power. Furthermore, additional sub-analyses were carried 
out in this M-A. The ability to detect significant differences from the null hypothesis 
is compromised when power is low. This has the potential for an increase in the risk 
of type II errors whereby the null hypotheses is incorrectly accepted resulting in a 
false negative. This is especially pertinent regarding the results from the sub-group 
analyses. It is reasonable to assume that the methodological quality of a study will 
affect the magnitude of the ES that will be reported (Borenstein et al., 2011).  
Furthermore, research suggests that as time passes and further research is carried out 
within a particular field the magnitude of ES changes resulting in a relationship with 
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the ES and publication date (Light & Pillemer, 1984). The tests of significant 
relationships in the sub-group analysis may suffer from being underpowered and 
therefore the ability to detect a significant difference may have been compromised 
resulting in potentially false negative results. The reduced power of this M-A may 
well be an artefact of the limited research which fits the inclusion and exclusion 
criteria of this M-A.   
The relative effects varied chronic health conditions have on QoL may have 
been different. Considering the multidimensional nature of QoL different conditions 
may have contributed to impairment on only selective domains. Chronic pain for 
example may have a major bearing on physical functioning (Flor & Turk, 2015) 
compared to epilepsy which may have a greater bearing on psychosocial functioning 
of QoL (Suurmeijer, Reuvekamp, & Aldenkamp, 2001). The ability to tease out these 
differences was beyond the scope of the data analysis in this M-A due to the small 
number of studies reporting on different conditions. This may explain to some extent 
why only a small to moderate ES was reported compared to much larger ESs found 
regarding different outcome measures (A-Tjak et al., 2015; Öst, 2008, 2014; Powers 
et al., 2009; Ruiz, 2012; Veehof et al., 2011). The aim of this M-A was to assess the 
efficacy of ACT across the chronic health population and therefore the subtle nuances 
within each condition regarding the relative effect on QoL were not assessed (Arnold 
et al., 2004) in part due to the small number of included studies. 
The current M-A conducted a systematic search for published work; however 
the potential for publication bias (Rosenthal, 1979) is a significant obstacle in M-A. 
The potential for studies reporting small or null findings and not being published 
through either the reluctance from authors or journal editors dismissing them is a real 
problem. The results from this study may well suffer from the effects of publication 
bias however the burden of publication bias should not be shouldered by M-As alone. 
Borenstein et al. (2011) argued that publication bias is a problem for any researcher 
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within any field of research using any form of analysis. The spotlight is often placed 
on M-As as there is an attempt to provide an accurate statistical synthesis of research 
compared to systematic or narrative reviews. There is an emphasis on observing and 
controlling for potential bias. Thus publication bias is a problem for all research and 
not just for M-As. 
4.6. Recommendations for Future Research 
There are several concerns which need to be addressed when considering 
future research based on the findings from this M-A, especially poor methodological 
standards which should be rectified. Many of the included studies suffered from low 
sample sizes. There was lack of evidence to suggest that a priori power calculations 
had been conducted and that adjustments had been made for attrition. A number of 
studies utilised a WLC/TAU group instead of an active control group. Also only three 
of the six active controls included an evidence based treatment. It is imperative to 
ensure that when comparing the efficacy of a new treatment that it is compared to a 
gold standard which has a strong evidence base. This is to ensure that the new 
approach is properly scrutinised and that conclusions drawn are valid. It is also 
important to scrutinise the treatment itself to ensure that the intervention is carried out 
as intended, including the philosophy, principles and processes. Given these 
methodological concerns there is a need for researchers to conduct larger scale RCTs 
using a priori power calculations and taking into account attrition rates. ACT should 
be compared to control groups that receive gold standard evidence based treatments. 
Furthermore treatment fidelity should be measured either through supervision or 
video/audio tapes to ensure that the intervention is true to the model.  
A number of studies in this M-A were excluded due to a lack of a QoL 
measure. There is now a much greater focus on the importance of QoL when 
measuring outcomes within a chronic health population (Naylor et al., 2012; The 
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Department of Health 2012, 2015). Psychological therapies are at the forefront of 
trying to improve the QoL for patients. It is therefore important that this construct is 
measured routinely when considering chronic health conditions. Treatments should 
consider targeting QoL as a primary outcome. The inclusion criteria should specify 
clear cut-off scores in order to target individuals that may benefit from an intervention 
and reduce the chance of celling effects. Based on the evidence from this M-A this 
could potentially result in larger ESs for QoL. 
It has not been possible in this M-A to tease apart the effective ingredients of 
ACT and if they are differentially effective for different disorders. The main aim of 
ACT is to improve psychological flexibility whilst in pursuit of a meaningful life. It 
therefore would be informative to measure psychological flexibility to better 
understand which elements of ACT are important and particularly how this relates to 
QoL. Research may uncover that parts of the ACT model (i.e., the hexiflex) are 
critical with regards to QoL. Does clarifying values and taking committed action 
towards living these values promote QoL? Does increasing acceptance and distancing 
from negative thoughts promote QoL? Are improvements in QoL linked to being 
present in the moment and just observing the self non-judegemntally? It may transpire 
that certain parts of the model are more or less effective within different populations. 
This would allow for a customised approach which targeted key areas to ensure that 
the most benefit could be attained from treatment.  
A decision was made in the current M-A to exclude studies that utilised a 
solely internet delivered or self-help intervention to ensure as far as possible that the 
treatments across studies were comparable. There is a growing evidence base 
regarding these approaches and specifically these treatment approaches (Buhrman et 
al., 2013; Gregg et al., 2007; Hesser et al., 2012; Johnston et al., 2010; Trompetter et 
al., 2015). Given that this M-A, to the authors knowledge, is the first to investigate the 
efficacy of ACT within the chronic health population it was decided to ensure that 
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interventions incorporated therapist/patient contact as experiential learning is a key 
process in the ACT approach (S. C. Hayes et al., 1999). Furthermore, there is a need 
to provide robust evidence for ACT as delivered in its conventional format prior to 
considering innovative delivery approaches. The use of internet and self-help 
approaches could make the interpretation of data difficult. Despite this, further 
investigation into this area does seem important. There are already internet-based 
(Ruwaard, Lange, Schrieken, & Emmelkamp, 2011) and self-help based (Coull & 
Morris, 2011) CBT protocols which have provided mixed results regarding their 
efficacy. The use of these approaches has been within the mild range of psychological 
disorders and therefore there is still the need for more evidence. Considering the large 
evidence base for CBT and inconclusive evidence for internet and self-help 
approaches there is clearly a need for more research within that field including in 
ACT. Potentially this would have major implications for clinical services and offer the 
prospect of delivering treatment to a large number of people. 
4.7. Conclusion 
The aim of this M-A was to investigate the efficacy of ACT on QoL in chronic 
health conditions. The findings from this M-A indicate that ACT is an efficacious 
treatment option within the chronic health population for improving QoL with a small 
to medium ES compared to controls. Improvements at post-intervention have been 
shown to be maintained at follow-up indicating that effects are enduring. Findings did 
however suggest that ACT was not significantly better at improving QoL when 
compared to an active control group. 
There has been a greater focus within the chronic health population on trying 
to improve QoL as an important feature of treatment rather than just managing 
physical symptoms. This has led to a greater role for psychological interventions. 
Clinically, it is important to provide treatment options within a time limited and cost 
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effective manner that address important and relevant outcomes. Findings from this M-
A indicate that ACT can improve QoL within the chronic health population. There is a 
need for further research that uses improved methodology which will clarify the 
picture regarding the efficacy of ACT when compared to active controls. 
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Appendix A: Data Extraction Form 
Data Collector: _________________ 
General 
1. Study ID:  
 
2. Reference: 
 
3. Year of Publication: 
 
4. Country of Origin: 
 
5. Type of Report: 
 Journal Article 
 Book chapter 
 Thesis or doctoral dissertation 
 Conference paper 
 Other: 
 
6. General Notes: 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________ 
 
Groups 
7. ACT Format: 
 Individual 
 Group 
 Other________________ 
 
8. Number of Control Groups: 
 
9. Format of Control Group/s: 
 Active therapy 
 Treatment as usual 
 Waiting list 
 Attention placebo 
 
10. Length of Each Treatment Session (minutes): 
 
11. Number of Sessions Offered: 
 
12. Mean Number of Sessions Attended: 
 
13. Total Length of Treatment Offered (minutes): 
 
Control Group 1 2 3 
Code    
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14. Mean Total Length of Treatment Received (minutes): 
 
15. Baseline Group Differences: 
 Not assessed 
 Assessed, Negligible Differences 
 Assessed, Some Differences, Judged Unimportant 
 Assessed, Some Differences, Judged Important (across several 
variables/major variable i.e. QoL) 
Samples 
16. Chronic Condition (description): 
 
17. Total Sample Size (baseline): 
 
18. Intervention Sample Size (baseline-completed): 
19. Sample Size of Control Group/s (baseline-
completed): 
 
20. Mean Age of Total Sample: 
 
21. Age SD/Range of Total Sample: 
 
22. Mean Age of Intervention Group: 
 
23. Age SD/Range of Intervention Group 
24. Mean Age of Control Group/s: 
 
25. Age SD/Range of Control Group/s: 
  
Design 
26. Randomisation: 
 Randomised 
 Non-randomised 
 
27. Additional Treatments Balanced Between Groups (e.g. medication): 
 Yes 
 No 
 State Treatment 
 
Control Group 1 2 3 
Code    
Control Group 1 2 3 
Code    
Control Group 1 2 3 
Code    
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28. ACT processes utilised 
 Acceptance 
 Cognitive defusion 
 Self-as-context 
 Observing self 
 Values 
 Committed action 
TOTAL: 
 
29. Outcome Measures: 
 
30. Length of Follow up: 
 
Effect Size/s – Record all effect sizes (M-A post and last follow-up only) 
31. Effect Size type: 
 Immediately post intervention 
 Follow up 
 
32. Intervention Group Mean (SD): 
 
33. Control Group Mean (SD):  
 
34. Direction of Effect: 
 Favours treatment 
 Favours control 
 Neither 
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Appendix B: The NICE Quality Appraisal Checklist for Quantitative 
Intervention Studies (NICE, 2012) 
Checklist items are worded so that 1 of 5 responses is possible: 
++ Indicates that for that particular aspect of study design, the study has 
been designed or conducted in such a way as to minimise the risk of 
bias. 
+ Indicates that either the answer to the checklist question is not clear 
from the way the study is reported, or that the study may not have 
addressed all potential sources of bias for that particular aspect of study 
design. 
− Should be reserved for those aspects of the study design in which 
significant sources of bias may persist. 
Not reported 
(NR) 
Should be reserved for those aspects in which the study under review 
fails to report how they have (or might have) been considered.  
Not 
applicable 
(NA) 
Should be reserved for those study design aspects that are not 
applicable given the study design under review (for example, allocation 
concealment would not be applicable for case control studies).  
 
In addition, the reviewer is requested to complete in detail the comments section of 
the quality appraisal form so that the grade awarded for each study aspect is as 
transparent as possible.  
Each study is then awarded an overall study quality grading for internal validity (IV) 
and a separate one for external validity (EV):  
++ All or most of the checklist criteria have been fulfilled, where they have not been 
fulfilled the conclusions are very unlikely to alter. 
+ Some of the checklist criteria have been fulfilled, where they have not been 
fulfilled, or not adequately described, the conclusions are unlikely to alter. 
− Few or no checklist criteria have been fulfilled and the conclusions are likely or 
very likely to alter. 
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Checklist 
Study identification:  
Study design: 
Refer to the glossary of study designs and the algorithm for 
classifying experimental and observational study designs to best 
describe the paper's underpinning study design 
 
Guidance topic:   
Assessed by:   
Section 1: Population 
1.1 Is the source population or source area well described?  
Was the country (e.g. developed or non-developed, type of healthcare 
system), setting (primary schools, community centres etc.), location 
(urban, rural), population demographics etc. adequately described? 
++ 
+ 
− 
NR 
NA 
Comments: 
1.2 Is the eligible population or area representative of the source 
population or area? 
Was the recruitment of individuals, clusters or areas well defined (e.g. 
advertisement, birth register)? 
Was the eligible population representative of the source? Were 
important groups under-represented? 
++ 
+ 
− 
NR 
NA 
Comments: 
1.3 Do the selected participants or areas represent the eligible 
population or area? 
Was the method of selection of participants from the eligible 
population well described? 
What % of selected individuals or clusters agreed to participate? Were 
there any sources of bias? 
Were the inclusion or exclusion criteria explicit and appropriate? 
++ 
+ 
− 
NR 
NA 
Comments: 
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Section 2: Method of allocation to intervention (or comparison) 
2.1 Allocation to intervention (or comparison). How was selection 
bias minimised? 
Was allocation to exposure and comparison randomised? Was it truly 
random ++ or pseudo-randomised + (e.g. consecutive admissions)? 
If not randomised, was significant confounding likely (−) or not (+)?  
If a cross-over, was order of intervention randomised? 
++ 
+ 
− 
NR 
NA 
Comments: 
2.2 Were interventions (and comparisons) well described and 
appropriate? 
Were interventions and comparisons described in sufficient detail (i.e. 
enough for study to be replicated)? 
Was comparisons appropriate (e.g. usual practice rather than no 
intervention)? 
++ 
+ 
-− 
NR 
NA 
Comments: 
2.3 Was the allocation concealed? 
Could the person(s) determining allocation of participants or clusters 
to intervention or comparison groups have influenced the allocation?  
Adequate allocation concealment (++) would include centralised 
allocation or computerised allocation systems. 
++ 
+ 
− 
NR 
NA 
Comments: 
2.4 Were participants or investigators blind to exposure and 
comparison? 
Were participants and investigators – those delivering or assessing the 
intervention kept blind to intervention allocation? (Triple or double 
blinding score ++) 
If lack of blinding is likely to cause important bias, score −. 
++ 
+ 
− 
NR 
NA 
Comments: 
2.5 Was the exposure to the intervention and comparison 
adequate? 
Is reduced exposure to intervention or control related to the 
intervention (e.g. adverse effects leading to reduced compliance) or 
++ 
+ 
− 
Comments: 
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fidelity of implementation (e.g. reduced adherence to protocol)? 
Was lack of exposure sufficient to cause important bias? 
NR 
NA 
2.6 Was contamination acceptably low? 
Did any in the comparison group receive the intervention or vice 
versa?  
If so, was it sufficient to cause important bias? 
If a cross-over trial, was there a sufficient wash-out period between 
interventions? 
++ 
+ 
− 
NR 
NA 
Comments: 
2.7 Were other interventions similar in both groups? 
Did either group receive additional interventions or have services 
provided in a different manner?  
Were the groups treated equally by researchers or other professionals?  
Was this sufficient to cause important bias? 
++ 
+ 
− 
NR 
NA 
Comments: 
2.8 Were all participants accounted for at study conclusion? 
Were those lost-to-follow-up (i.e. dropped or lost pre-,during or post-
intervention) acceptably low (i.e. typically <20%)?  
Did the proportion dropped differ by group? For example, were drop-
outs related to the adverse effects of the intervention? 
++ 
+ 
− 
NR 
NA 
Comments: 
2.9 Did the setting reflect usual UK practice? 
Did the setting in which the intervention or comparison was delivered 
differ significantly from usual practice in the UK? For example, did 
participants receive intervention (or comparison) condition in a 
hospital rather than a community-based setting? 
++ 
+ 
− 
NR 
NA 
Comments: 
2.10 Did the intervention or control comparison reflect usual UK 
practice? 
Did the intervention or comparison differ significantly from usual 
++ 
+ 
Comments: 
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practice in the UK? For example, did participants receive intervention 
(or comparison) delivered by specialists rather than GPs? Were 
participants monitored more closely? 
− 
NR 
NA 
Section 3: Outcomes (Only rate QoL measures) 
3.1 Were outcome measures reliable? 
Were outcome measures subjective or objective (e.g. biochemically 
validated nicotine levels ++ vs self-reported smoking −)? 
How reliable were outcome measures (e.g. inter- or intra-rater 
reliability scores)? 
Was there any indication that measures had been validated (e.g. 
validated against a gold standard measure or assessed for content 
validity)? 
++ 
+ 
− 
NR 
NA 
Comments: 
3.2 Were all outcome measurements complete? 
Were all or most study participants who met the defined study 
outcome definitions likely to have been identified? 
++ 
+ 
− 
NR 
NA 
Comments: 
3.3 Were all important outcomes assessed? 
Were all important benefits and harms assessed?  
Was it possible to determine the overall balance of benefits and harms 
of the intervention versus comparison? 
++ 
+ 
− 
NR 
NA 
Comments: 
3.4 Were outcomes relevant? 
Where surrogate outcome measures were used, did they measure what 
they set out to measure? (e.g. a study to assess impact on physical 
activity assesses gym membership – a potentially objective outcome 
measure – but is it a reliable predictor of physical activity?) 
++ 
+ 
NR 
NA 
Comments: 
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3.5 Were there similar follow-up times in exposure and 
comparison groups? 
If groups are followed for different lengths of time, then more events 
are likely to occur in the group followed-up for longer distorting the 
comparison.  
Analyses can be adjusted to allow for differences in length of follow-
up (e.g. using person-years). 
++ 
+ 
NR 
NA 
Comments: 
3.6 Was follow-up time meaningful? 
Was follow-up long enough to assess long-term benefits or harms?  
Was it too long, e.g. participants lost to follow-up? 
++ 
+ 
− 
NR 
NA 
Comments: 
Section 4: Analyses 
4.1 Were exposure and comparison groups similar at baseline? If 
not, were these adjusted? 
Were there any differences between groups in important confounders 
at baseline?  
If so, were these adjusted for in the analyses (e.g. multivariate 
analyses or stratification). 
Were there likely to be any residual differences of relevance? 
++ 
+ 
− 
NR 
NA 
Comments: 
4.2 Was intention to treat (ITT) analysis conducted? 
Were all participants (including those that dropped out or did not fully 
complete the intervention course) analysed in the groups (i.e. 
intervention or comparison) to which they were originally allocated? 
++ 
+ 
− 
NR 
NA 
Comments: 
4.3 Was the study sufficiently powered to detect an intervention 
effect (if one exists)? 
A power of 0.8 (that is, it is likely to see an effect of a given size if 
++ 
+ 
Comments: 
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one exists, 80% of the time) is the conventionally accepted standard. 
Is a power calculation presented? If not, what is the expected effect 
size? Is the sample size adequate? 
− 
NR 
NA 
4.4 Were the estimates of effect size given or calculable? 
Were effect estimates (e.g. relative risks, absolute risks) given or 
possible to calculate? 
++ 
+ 
− 
NR 
NA 
Comments: 
4.5 Were the analytical methods appropriate? 
Were important differences in follow-up time and likely confounders 
adjusted for?  
If a cluster design, were analyses of sample size (and power), and 
effect size performed on clusters (and not individuals)? 
Were subgroup analyses pre-specified? 
++ 
+ 
− 
NR 
NA 
Comments: 
4.6 Was the precision of intervention effects given or calculable? 
Were they meaningful? 
Were confidence intervals or p values for effect estimates given or 
possible to calculate?  
Were CI's wide or were they sufficiently precise to aid decision-
making? If precision is lacking, is this because the study is under-
powered? 
++ 
+ 
− 
NR 
NA 
Comments: 
Section 5: Summary 
5.1 Are the study results internally valid (i.e. unbiased)? 
How well did the study minimise sources of bias (i.e. adjusting for 
potential confounders)?  
Were there significant flaws in the study design? 
++ 
+ 
− 
Comments: 
5.2 Are the findings generalisable to the source population (i.e. ++ Comments: 
127 
externally valid)? 
Are there sufficient details given about the study to determine if the 
findings are generalisable to the source population? Consider: 
participants, interventions and comparisons, outcomes, resource and 
policy implications. 
+ 
− 
 
  
 
 
